Use of hypnotics and sedatives

RX_N05C

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N05C 1 out of 7 registries used, show all original rules.	90973
4. Check minimum number of events Min. number of events 3	90973
5. Include endpoints None	90973
6. Filter based on genotype QC (FinnGen only)	88090

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	RX_N05C
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N05C
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Use of hypnotics and sedatives based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	791068	467501	316347
Only index persons	649689	398173	251516
Unadjusted period prevalence (%)
Whole population	11.52	13.39	8.84
Only index persons	12.69	14.64	9.60
Median age at first event (years)
Whole population	57.02	58.33	54.85
Only index persons	54.22	55.71	51.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	88090	52422	35668
Unadjusted period prevalence (%)	17.68	18.60	16.34
Median age at first event (years)	52.28	50.25	55.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
67237: Matched controls
385877

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z71.8

ICD-10 Finland

Other specified counselling

1.4

321.5

17672

76323

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

320.9

21543

96495

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

320.1

3619

10162

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

319.3

7797

28090

J01FA10

ATC

azithromycin; systemic

1.4

317.8

34124

165296

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

315.8

8488

31342

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.7

313.6

1207

1889

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

309.7

9467

36067

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.2

307.7

2261

4111

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.3

307.7

992

916

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

307.7

5491

15998

N05AB03

ATC

perphenazine; systemic, rectal

5.5

307.7

3166

3463

N05BA12

ATC

alprazolam; oral

4.4

307.7

9541

13860

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

15176

51056

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

307.7

1159

1675

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.4

307.7

1099

1458

N06AX17

ATC

milnacipran; oral

5.5

307.7

823

872

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

307.7

10356

39310

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

307.7

6853

15517

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.6

307.7

2121

3424

N05AB01

ATC

dixyrazine; systemic

11.0

307.7

1160

616

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.4

307.7

1152

1239

N05BA02

ATC

chlordiazepoxide; systemic

8.8

307.7

2392

1616

H03AA01

ATC

levothyroxine sodium; systemic

1.6

307.7

13104

51195

F34.1

ICD-10 Finland

Dysthymia

4.1

307.7

2906

4223

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.5

307.7

888

690

A02BC01

ATC

omeprazole; systemic

1.9

307.7

17783

61493

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

6.5

307.7

741

663

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

24284

98434

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.0

307.7

5057

7604

N05AA01

ATC

chlorpromazine; systemic, rectal

8.1

307.7

1225

887

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

307.7

34795

159760

C07AB07

ATC

bisoprolol; oral

1.8

307.7

30192

119547

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

307.7

9423

32738

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

307.7

10113

37713

R42

ICD-10 Finland

Dizziness and giddiness

1.5

307.7

12567

50226

N05CD02

ATC

nitrazepam; oral

34.2

307.7

1725

297

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

307.7

3637

9139

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.9

307.7

1982

3010

N03AX16

ATC

[U] pregabalin

2.6

307.7

18002

47264

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

307.7

2877

7191

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

307.7

7622

26972

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

307.7

11406

21696

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.2

307.7

2340

2242

L28

ICPC

Limited function/disability (L)

1.7

307.7

9436

33659

N06AX03

ATC

mianserin; oral

8.5

307.7

5214

3781

A04

ICPC

Weakness/tiredness general

1.7

307.7

8021

28731

N05CD08

ATC

midazolam; nasal, systemic

16.4

307.7

2340

844

G47.3

ICD-10 Finland

Sleep apnoea

1.5

307.7

13192

53525

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

26950

102752

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

307.7

2407

5312

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.9

307.7

867

856

N03AX12

ATC

[U] gabapentin; oral

2.4

307.7

11742

31170

H02AB06

ATC

prednisolone; systemic

1.6

307.7

29941

127683

F61.0

ICD-10 Finland

Mixed personality disorders

6.1

307.7

1591

1532

F32

ICD-10 Finland

Depressive episode

2.5

307.7

3622

8542

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

16900

65695

L03

ICPC

Low back symptom/complaint

1.5

307.7

15698

64939

N05AD03

ATC

melperone; systemic

7.0

307.7

1007

835

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.4

307.7

1622

2158

N05AX08

ATC

risperidone; systemic

3.3

307.7

6507

12017

UJF32

NOMESCO Finland

Coloscopy

1.6

307.7

15035

58838

M03BX02

ATC

tizanidine; oral

1.6

307.7

40259

184361

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

307.7

16994

55061

M54.5

ICD-10 Finland

Low back pain

1.6

307.7

21998

91714

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.9

307.7

1695

2567

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.9

307.7

2840

4291

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

9970

34348

P16

ICPC

Acute alcohol abuse

4.4

307.7

1241

1636

P06

ICPC

Sleep disturbance

2.9

307.7

9337

20275

N05AH03

ATC

olanzapine; systemic

5.4

307.7

6526

7504

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.8

307.7

1921

2371

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

307.7

14059

53767

UKC02

NOMESCO Finland

Cystoscopy

1.7

307.7

8655

31657

N06AG02

ATC

moclobemide; oral

4.8

307.7

3708

4663

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

7.0

307.7

1299

1084

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.8

307.7

3562

3150

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

34327

154976

J01MA12

ATC

levofloxacin; systemic

1.7

307.7

10816

38943

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

307.7

10576

40079

N03AE01

ATC

clonazepam; systemic

4.4

307.7

5022

6992

A01

ICPC

Pain general/multiple sites

2.0

307.7

5229

15503

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.6

307.7

1817

1617

C01DA14

ATC

isosorbide mononitrate; oral

1.7

307.7

7641

27144

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.4

307.7

1507

1367

A28

ICPC

Limited function/disability NOS

1.8

307.7

8879

29866

G04CA02

ATC

tamsulosin; oral

1.6

307.7

12888

50219

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

307.7

12781

51548

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

31021

108171

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.5

307.7

969

869

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.5

307.7

729

652

R06AE07

ATC

cetirizine; oral

1.5

307.7

26484

118110

N06AB05

ATC

paroxetine; oral

3.9

307.7

5268

8182

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

20894

88369

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

307.7

4798

14051

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

16417

58861

N06AX26

ATC

vortioxetine; oral

3.0

307.7

5685

11422

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

18340

65712

N03AX11

ATC

topiramate; oral

3.1

307.7

1649

3087

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.2

307.7

1038

978

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.5

307.7

1227

1100

R4110

NOMESCO Finland

Physiotherapy

1.5

307.7

15789

64678

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.5

307.7

1893

3125

A03CA02

ATC

clidinium and psycholeptics; oral

2.8

307.7

3502

7539

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

30360

117832

Z3226

NOMESCO Finland

Physiotherapist

1.7

307.7

10761

37890

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.4

307.7

2635

2426

J01FA06

ATC

roxithromycin; oral

1.5

307.7

23581

103870

SPAT1240

SPAT

Therapeutic discussion

2.2

307.7

6803

19133

Z3231

NOMESCO Finland

Registered nurse

1.6

307.7

16535

64058

ZY010

NOMESCO Finland

Hospital outpatient

2.7

307.7

3404

7489

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.8

307.7

1942

3015

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.1

307.7

4698

5603

J01AA02

ATC

doxycycline; systemic

1.7

307.7

49923

242294

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.0

307.7

595

381

N06AB10

ATC

escitalopram; oral

3.0

307.7

17828

41135

F51.0

ICD-10 Finland

Nonorganic insomnia

4.7

307.7

16712

25625

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.0

307.7

1085

1252

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

307.7

23954

108958

N06AX16

ATC

venlafaxine; oral

4.0

307.7

14008

23896

M01AH01

ATC

celecoxib; oral

1.7

307.7

10424

36718

F31

ICD-10 Finland

Bipolar affective disorder

6.1

307.7

1070

1028

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

307.7

27857

115991

N05AX12

ATC

aripiprazole; systemic

4.6

307.7

3662

4724

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.7

307.7

7099

9470

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.9

307.7

1514

1821

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.9

307.7

1728

2605

N05CD05

ATC

triazolam; oral, sublingual

24.0

307.7

1091

265

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

307.7

13055

52506

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.8

307.7

2013

3079

N03AX09

ATC

lamotrigine; oral

4.8

307.7

4721

6022

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

15848

66595

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

307.7

2193

4773

N06AB06

ATC

sertraline; oral

3.7

307.7

10299

18013

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

307.7

16685

63564

F31.8

ICD-10 Finland

Other bipolar affective disorders

6.0

307.7

1701

1656

SPAT1254

SPAT

Administration of medicine

1.7

307.7

7818

27981

N06AA06

ATC

trimipramine; systemic

10.1

307.7

2484

1462

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.8

307.7

736

623

J02AC01

ATC

fluconazole; systemic

1.5

307.7

23653

101959

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

307.7

23112

91978

A02BA02

ATC

ranitidine; systemic

2.1

307.7

12350

37552

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.3

307.7

6328

9198

N03AG01

ATC

valproic acid; systemic, rectal

4.3

307.7

5586

8038

C07AA05

ATC

propranolol; systemic

2.6

307.7

16095

41166

M01AC06

ATC

meloxicam; systemic, rectal

1.5

307.7

20854

89810

N06AB08

ATC

fluvoxamine; oral

5.4

307.7

2265

2456

N05CD07

ATC

temazepam; oral

21.7

307.7

17241

6024

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.8

307.7

1506

2322

R51.80

ICD-10 Finland

Headache

1.7

307.7

9129

32411

N03AF01

ATC

carbamazepine; oral, rectal

2.7

307.7

3201

7002

N05CF01

ATC

zopiclone; oral

34.3

307.7

52151

35287

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

22912

93210

M01AX17

ATC

nimesulide; oral

1.6

307.7

13380

51759

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.0

307.7

1658

1382

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

6.2

307.7

760

705

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

307.7

12769

49075

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.6

307.7

814

844

M01AH02

ATC

rofecoxib; oral

1.8

307.7

6845

23360

N04AA02

ATC

biperiden; systemic

6.3

307.7

1673

1549

N06AB03

ATC

fluoxetine; oral

4.1

307.7

11450

18514

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

307.7

3781

9425

N05BA04

ATC

oxazepam; oral

4.8

307.7

27073

47161

N06AX18

ATC

reboxetine; oral

5.8

307.7

846

844

N07BB01

ATC

disulfiram; oral

5.3

307.7

4482

5103

Z2445

NOMESCO Finland

Psychologist

2.5

307.7

2374

5467

N06AB04

ATC

citalopram; systemic

4.0

307.7

20250

37629

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.5

307.7

4667

4407

C08CA01

ATC

amlodipine; oral

1.5

307.7

21005

89677

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

307.7

5396

16772

N05CB02

ATC

barbiturates in combination with other drugs

4.7

307.7

1161

1437

Z2446

NOMESCO Finland

Social worker

2.6

307.7

4330

9881

N05AL01

ATC

sulpiride; systemic

7.0

307.7

1193

991

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

307.7

11070

42893

N05BE01

ATC

buspirone; oral

7.2

307.7

2995

2468

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

307.7

2765

5979

M48.0

ICD-10 Finland

Spinal stenosis

1.8

307.7

6466

21317

N06AA04

ATC

clomipramine; systemic

4.8

307.7

1222

1477

S18

ICPC

Laceration/cut

1.4

307.7

25802

118602

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.1

307.7

6839

13414

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

27758

110031

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

307.7

9177

30497

N05AD01

ATC

haloperidol; systemic

4.1

307.7

2328

3336

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

14748

54392

N06AX11

ATC

mirtazapine; oral

7.0

307.7

38692

62911

N05BA01

ATC

diazepam; systemic, rectal

5.4

307.7

13970

17725

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

45309

197135

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.6

307.7

933

970

N06AX21

ATC

duloxetine; oral

3.3

307.7

10000

19558

N05AH04

ATC

quetiapine; oral

6.0

307.7

20962

27199

C03CA01

ATC

furosemide; systemic

1.9

307.7

17631

61443

E0000UV, ,

ATC

1.4

307.7

24271

109429

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

307.7

3267

7491

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.5

307.7

1974

1781

P18

ICPC

Medication abuse

10.8

307.7

610

326

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

307.7

7889

28237

P99

ICPC

Psychological disorders other

4.1

307.7

2309

3313

C10AA01

ATC

simvastatin; oral

1.5

307.7

22552

96890

N05CF02

ATC

zolpidem; oral

17.6

307.7

29057

16035

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

307.7

12762

48694

J01DA01

ATC

[U] cefalexin

1.5

307.7

38100

182671

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.3

307.7

3531

8910

V03AA01, ,

ATC

7.1

307.7

1428

1178

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

307.7

1848

3724

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

307.7

3107

7578

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.2

307.7

1734

1636

J01FF01

ATC

clindamycin; systemic

1.5

307.7

16092

65816

M79.6

ICD-10 Finland

Pain in limb

1.5

307.7

25150

108641

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

19007

73611

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

22.4

307.7

430

111

A02BC03

ATC

lansoprazole; oral

1.9

307.7

18553

65130

N05AA02

ATC

levomepromazine; systemic

10.9

307.7

4994

2824

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

307.7

7977

27078

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.9

307.7

921

776

R02

ICPC

Shortness of breath/dyspnoea

1.7

307.7

7173

24699

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

7.0

307.7

703

580

M02AA07

ATC

piroxicam; topical

1.5

307.7

20715

87006

N02BF02

ATC

pregabalin; oral

2.9

307.7

4179

8593

N05AF03

ATC

chlorprothixene; systemic

9.2

307.7

2975

1922

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

307.7

6072

19783

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.5

307.7

1585

2066

N06AX05

ATC

trazodone; oral

9.9

307.7

2845

1722

A02BA04

ATC

nizatidine; systemic

2.0

307.7

4138

11999

A06AD11

ATC

lactulose; oral

2.5

307.7

9799

24745

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

16.0

307.7

451

163

C07AB02

ATC

metoprolol; systemic

1.7

307.7

11076

40016

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.6

307.7

850

745

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.5

307.7

988

1269

N06AX12

ATC

bupropion; oral

3.4

307.7

6169

11152

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.7

307.7

8487

14328

N05AN01

ATC

lithium; oral

6.8

307.7

2420

2097

J01DB01

ATC

cefalexin; oral

1.6

307.7

52752

268808

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

307.7

5713

18471

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.9

307.7

3648

7395

N02AA05

ATC

oxycodone; systemic

2.1

307.7

10656

32308

N02BE01

ATC

paracetamol; systemic, rectal

2.0

307.7

58070

293088

P76

ICPC

Depressive disorder

2.9

307.7

4804

10002

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

17.1

307.7

462

156

P74

ICPC

Anxiety disorder/anxiety state

2.9

307.7

2752

5549

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

9618

31299

P72

ICPC

Schizophrenia

4.3

307.7

1352

1829

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.7

307.7

1370

1046

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

6.9

307.7

1239

1049

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

19.2

307.7

512

154

R03BB04

ATC

tiotropium bromide; inhalant

2.0

307.7

5814

17226

N05AH02

ATC

clozapine; systemic

4.7

307.7

1469

1827

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

7.0

307.7

1369

1140

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

307.7

10584

40568

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

307.7

24475

104955

R06.0

ICD-10 Finland

Dyspnoea

1.7

307.7

16022

59014

F51

ICD-10 Finland

Nonorganic sleep disorders

3.8

307.7

3469

5412

H02AB07

ATC

prednisone; oral

1.7

307.7

7762

27534

P29

ICPC

Psychological sympt/compl other

2.6

307.7

4630

10807

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

14900

54198

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.5

307.7

3864

5213

S06.0

ICD-10 Finland

Concussion

1.8

307.7

6201

20409

N06AA09

ATC

amitriptyline; systemic

3.9

307.7

7950

12896

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.8

307.7

2235

3475

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

307.7

9204

33693

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.6

307.7

1533

1603

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

307.7

6705

16392

M01AB05

ATC

diclofenac; systemic, rectal

1.5

307.7

41792

199463

F10.24

ICD-10 Finland

Alcohol depence active use

5.7

307.7

1293

1329

P03

ICPC

Feeling depressed

2.2

307.7

6306

16997

N06AA12

ATC

doxepin; systemic

7.7

307.7

5301

4221

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

307.7

18340

71520

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

9193

21502

M01AH05

ATC

etoricoxib; oral

1.4

307.7

37913

182045

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

307.7

7457

16489

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.9

307.7

1356

2042

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

307.7

17215

73758

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.6

307.7

1593

2033

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

307.7

14987

61113

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

24342

104176

N02BF01

ATC

gabapentin; oral

2.3

307.7

5109

13602

N05AF01

ATC

flupentixol; systemic

6.0

307.7

1198

1154

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

10799

40955

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

307.7

31413

147621

Z2221

NOMESCO Finland

Medical doctor

1.5

307.7

15811

66647

N05AC02

ATC

thioridazine; oral

5.1

307.7

1430

1634

N02AC04

ATC

dextropropoxyphene; oral

2.8

307.7

2002

4236

N06AX22

ATC

agomelatine; oral

5.0

307.7

2003

2371

N05AF05

ATC

zuclopenthixol; systemic

7.0

307.7

831

690

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.8

307.7

1762

2157

P15

ICPC

Chronic alcohol abuse

4.2

307.7

2444

3440

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

34606

161194

J01EA01

ATC

trimethoprim; systemic

1.5

307.7

14330

58502

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

307.7

13934

47199

N04BC05

ATC

pramipexole; oral

2.6

307.7

4885

11125

P01

ICPC

Feeling anxious/nervous/tense

2.0

307.7

7202

21402

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

307.7

21048

91998

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.9

307.7

1763

2633

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.3

307.7

6277

9044

N05BA06

ATC

lorazepam; systemic, sublingual

5.0

307.7

4525

5500

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.3

307.7

965

892

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.7

307.7

1513

1869

AA400

NOMESCO Finland

Electroconvulsive therapy

6.6

305.6

641

566

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.1

304.2

682

651

N05BA05

ATC

potassium clorazepate; oral

6.9

303.5

610

511

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

303.4

6193

21210

B01AB05

ATC

enoxaparin; parenteral

1.4

302.6

17352

75363

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.3

302.3

968

1309

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

300.9

15372

65316

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.3

300.3

460

258

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.2

300.0

783

878

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

299.6

1910

4116

R52.2

ICD-10 Finland

Other chronic pain

2.6

299.5

2143

4905

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

299.4

17022

73783

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

299.0

3384

9500

C10AA05

ATC

atorvastatin; oral

1.4

297.2

22209

100984

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

296.7

20485

91893

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

17.8

295.9

352

114

WX002

NOMESCO Finland

Sedation and analgesia

1.5

295.8

10383

40800

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

295.6

43176

218480

A10BA02

ATC

metformin; oral

1.4

293.2

15246

64944

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

9.0

292.7

487

313

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

292.4

5111

16699

R11

ICD-10 Finland

Nausea and vomiting

1.9

292.0

4693

14929

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

9.4

291.9

472

290

H02AB04

ATC

methylprednisolone; systemic

1.6

291.7

8031

29786

N05AE04

ATC

ziprasidone; systemic

7.2

290.5

563

450

A03FA02

ATC

cisapride; oral, rectal

2.0

288.2

3910

11740

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

287.1

27725

131213

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.5

286.0

1203

2007

R01AD09

ATC

mometasone; nasal

1.4

285.8

26651

125406

K59.0

ICD-10 Finland

Constipation

2.1

284.8

3024

8272

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

284.8

3392

9707

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

283.2

6732

24026

G04BD12

ATC

mirabegron; oral

1.7

280.5

5898

20347

N06AA10

ATC

nortriptyline; systemic

3.2

279.6

1318

2374

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

279.6

8149

30626

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

279.5

11075

44618

ZXE00

NOMESCO Finland

One hour or less

1.4

278.7

22188

101662

ZXA00

NOMESCO Finland

Right side

1.5

277.1

14017

59289

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.6

274.6

1942

4417

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

273.6

4591

14796

A01AB09

ATC

miconazole; local oral

1.8

273.3

4514

14474

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

272.6

32826

160220

M25.5

ICD-10 Finland

Pain in joint

1.4

272.3

18046

80111

C03DA01

ATC

spironolactone; oral

1.7

272.2

6164

21698

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

272.1

2414

6116

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

271.9

6672

23996

G44.2

ICD-10 Finland

Tension-type headache

1.6

271.6

7598

28253

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

271.5

6605

23702

ZY000

NOMESCO Finland

Hospital inpatient

4.3

271.3

868

1173

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

271.3

16554

72428

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

270.1

4739

15485

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

7.0

270.0

536

442

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.2

269.8

1296

2363

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

8.0

269.7

485

350

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

269.6

2960

8203

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.8

269.4

1590

3282

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

268.3

4636

15076

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

5.9

268.2

614

600

V03AB30, ,

ATC

7.3

268.0

515

407

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

7.3

268.0

515

407

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

268.0

22066

101485

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

267.7

4883

16146

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

267.6

6811

24724

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

266.7

22086

101648

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

266.6

8011

30300

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

266.3

2642

7025

SPAT1301

SPAT

No procedures

1.4

266.2

17057

75220

A07AA02

ATC

nystatin; oral

2.1

266.0

3081

8718

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

265.4

5998

21094

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

264.8

5492

18856

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

264.2

2808

7680

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.7

264.1

1650

3515

R35

ICD-10 Finland

Polyuria

2.0

263.8

3617

10890

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

263.8

5495

18889

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

8.0

263.6

474

342

D07AC01

ATC

betamethasone; topical

1.4

261.1

20353

92685

A07DA03

ATC

loperamide; oral

2.5

261.0

1894

4363

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

7.2

260.1

503

401

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.8

259.2

1598

3379

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

7.1

258.9

506

409

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

257.6

7123

26387

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

257.3

9905

39582

W78

ICPC

Pregnancy

0.5

257.0

2298

26735

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

256.7

2241

5635

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

16.8

255.7

311

107

F33

ICD-10 Finland

Recurrent depressive disorder

2.9

254.3

1391

2747

N07BA03

ATC

varenicline; oral

2.1

253.9

2891

8124

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

252.5

4872

45141

C05AA08

ATC

fluocortolone; rectal, topical

1.6

252.4

7481

28174

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.3

252.4

1171

2087

SPAT1234

SPAT

Support of social functional capacity

2.2

251.8

2636

7163

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.1

251.5

845

1189

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.6

251.4

525

461

G04BD07

ATC

tolterodine; oral

2.2

250.6

2410

6321

G04BD08

ATC

solifenacin; oral

2.0

249.1

3301

9814

R50.9

ICD-10 Finland

Fever, unspecified

1.6

249.1

8185

31570

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

7.4

248.6

473

369

M01AB55

ATC

diclofenac, combinations; oral

2.0

248.1

3371

10112

SPAT1197

SPAT

Extensive health check-up of expecting family

0.4

247.8

1867

23109

ZXA05

NOMESCO Finland

Left side

1.4

246.8

12959

55018

Z72.2

ICD-10 Finland

Drug use

7.6

246.4

459

348

T90

ICPC

Diabetes non-insulin dependent

1.4

246.2

12380

52134

B01AA03

ATC

warfarin; systemic

1.5

245.6

9417

37562

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

245.6

10635

43501

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

245.4

6156

53619

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

244.1

10857

44639

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

241.3

4329

14224

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

240.2

13750

59256

M02AA10

ATC

ketoprofen; topical

1.5

239.1

8441

33057

Z72.1

ICD-10 Finland

Alcohol use

3.9

237.7

848

1252

D11

ICPC

Diarrhoea

1.6

236.8

6439

23723

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

236.3

6567

24324

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

235.4

13841

59898

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

235.1

3427

10528

R03BA01

ATC

beclometasone; inhalant

1.6

234.6

7547

28938

P19

ICPC

Drug abuse

4.8

234.4

663

803

J01MA14

ATC

moxifloxacin; systemic

1.7

234.2

4794

16373

SPAT1216

SPAT

Assessment of functional ability

1.6

233.8

7620

29301

N06AA22, ,

ATC

7.2

233.8

453

362

ZXD05

NOMESCO Finland

Urgent procedure

1.4

233.7

17180

77187

205

Kela drug reimbursment

Chronic hypertension

1.4

232.6

13338

57450

M01AX05

ATC

glucosamine; oral

1.5

231.7

9072

36303

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.6

231.4

1601

3598

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

10.4

231.1

351

194

F40.1

ICD-10 Finland

Social phobias

2.8

228.2

1372

2860

M04AA01

ATC

allopurinol; systemic

1.6

227.9

6492

24177

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

227.9

2620

7384

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.6

226.5

666

836

R33

ICD-10 Finland

Retention of urine

1.8

226.0

3995

13059

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

225.3

4925

17125

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.2

225.1

2205

5825

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

224.7

5996

21969

R52.9

ICD-10 Finland

Pain, unspecified

1.7

223.4

5273

18717

A29

ICPC

General symptom/complaint other

1.6

223.4

6428

23989

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

223.3

14362

63031

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

222.0

10690

44539

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

222.0

5312

18923

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

221.9

6671

25157

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

221.8

1784

4317

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.8

221.7

373

244

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

220.9

24305

115799

R03BA05

ATC

fluticasone; inhalant

1.5

220.9

9862

40490

M79.7

ICD-10 Finland

Fibromyalgia

2.3

220.4

1927

4845

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

219.7

1718

4102

R01AD08

ATC

fluticasone; nasal

1.4

218.4

16026

71825

WX892

NOMESCO Finland

Monitored bed care

1.8

217.4

3969

13097

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

217.1

14081

61838

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

6.2

216.7

477

446

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

215.7

56960

306743

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

215.6

43121

222536

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.9

215.2

590

694

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

215.1

11525

48945

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

214.0

13311

58019

F41.00

ICD-10 Finland

Moderate panic disorder

3.3

213.5

978

1728

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

213.3

14592

64616

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.2

213.2

547

603

R03DC03

ATC

montelukast; oral

1.5

213.2

8889

35976

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

212.8

14311

63189

F61

ICD-10 Finland

Mixed and other personality disorders

7.3

212.7

407

320

D12

ICPC

Constipation

2.3

211.9

1821

4542

A02BX02

ATC

sucralfate; oral

2.2

211.7

2007

5228

J01MA06

ATC

norfloxacin; oral

1.6

211.1

6727

25692

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

210.1

16037

72242

J01CA04

ATC

amoxicillin; systemic

1.3

210.1

50061

264267

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

209.9

3738

12238

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

209.5

10333

43192

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

209.3

3825

12620

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

5.0

209.2

568

662

XKD00

NOMESCO Finland

Uroflowmetry

1.5

209.1

7887

31257

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

208.7

6880

26476

EBA00

NOMESCO Finland

Extraction of tooth

1.3

208.1

19525

90715

R03BA02

ATC

budesonide; inhalant

1.5

208.0

9544

39346

SPAT1243

SPAT

Psychiatric/psychological examination

2.5

207.8

1482

3381

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

207.2

6702

25678

A06AC51

ATC

ispaghula, combinations; oral

2.0

206.2

2531

7308

SPAT1260

SPAT

Consultation of another employee

1.5

205.8

9244

37942

SPAT1265

SPAT

Breathalyser

4.2

205.6

667

912

R07.3

ICD-10 Finland

Other chest pain

1.6

205.1

5284

19167

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

205.0

10937

46362

SPAT1379

SPAT

Health check-up of pregnant person

0.4

204.2

1478

18631

SPAT1252

SPAT

Overall medication plan or its review

1.8

204.0

3360

10733

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

202.7

11843

51003

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

202.6

14962

66979

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

202.6

2794

8412

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

202.2

3470

11227

M01AB01

ATC

indometacin; systemic, rectal

1.8

202.2

3701

12213

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.7

202.1

577

705

J05AB01

ATC

aciclovir; systemic

1.4

201.9

11642

50018

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

201.9

4869

17362

S01.0

ICD-10 Finland

Open wound of scalp

1.7

200.8

4047

13738

L08

ICPC

Shoulder symptom/complaint

1.4

200.7

11437

49027

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

200.5

4462

15572

SPAT1380

SPAT

Postpartum check-up

0.4

200.2

1120

15635

G04CA01

ATC

alfuzosin; oral

1.6

199.8

6227

23643

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

199.5

4650

16430

SFA30

NOMESCO Finland

Three-surface restoration

1.3

199.3

23809

114240

W19

ICD-10 Finland

Unspecified fall

1.6

199.2

5081

18377

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.5

199.2

594

755

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

199.1

12549

54722

U02

ICPC

Urinary frequency/urgency

1.5

198.5

6895

26822

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

7.1

197.8

390

319

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

197.8

3829

12846

D01

ICPC

Abdominal pain/cramps general

1.6

197.6

5953

22423

F32.8

ICD-10 Finland

Other depressive episodes

3.2

196.4

940

1709

L13

ICPC

Hip symptom/complaint

1.5

195.0

8836

36295

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

194.7

3020

9459

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

193.8

8077

32632

R60.0

ICD-10 Finland

Localized oedema

1.6

193.3

6092

23180

E66.8

ICD-10 Finland

Other obesity

1.9

193.3

3095

9794

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

193.2

2319

6637

S29

ICPC

Skin symptom/complaint other

1.4

192.2

9778

41035

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

191.9

5605

20950

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

191.5

1464

3456

N03AF02

ATC

oxcarbazepine; oral

2.2

191.3

1794

4649

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.5

191.1

2226

23881

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

191.0

3851

13067

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.2

190.6

913

1661

N06BA04

ATC

methylphenidate; oral

2.3

190.5

1637

4082

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

190.1

3167

10147

R05

ICPC

Cough

1.4

189.7

12570

55206

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

189.7

9192

38221

F22.0

ICD-10 Finland

Delusional disorder

3.3

189.6

846

1469

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

12.7

189.5

259

117

R55

ICD-10 Finland

Syncope and collapse

1.6

189.3

5550

20760

E000001, ,

ATC

1.4

189.0

10531

44911

A02BA03

ATC

famotidine; systemic

2.2

188.9

1876

4981

JN4BD

NOMESCO Finland

Extensive body CT

1.6

188.6

5134

18863

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

21.9

188.3

209

N30.0

ICD-10 Finland

Acute cystitis

1.5

187.7

8093

32900

N05BB01

ATC

hydroxyzine; systemic

1.8

187.6

3151

10121

A46

ICD-10 Finland

Erysipelas

1.5

187.1

7459

29847

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

186.6

5031

18438

N05AC01

ATC

periciazine; systemic

7.9

186.1

336

244

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

186.0

6854

26978

D07AA02

ATC

hydrocortisone; topical

1.5

186.0

7291

29073

J01FA09

ATC

clarithromycin; systemic

1.3

185.7

17057

78715

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

185.3

2230

6387

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

185.1

1507

3665

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

184.8

17337

80239

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

184.6

7200

28677

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

182.8

4238

14940

G03FA01

ATC

norethisterone and estrogen; systemic

1.6

182.6

5766

21934

C09CA06

ATC

candesartan; oral

1.4

182.2

12599

55666

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

10.1

182.0

281

160

R13

ICD-10 Finland

Dysphagia

1.8

181.9

3374

11170

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

181.7

2360

6951

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

15.6

181.4

227

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

8.0

181.0

326

236

R03AC03

ATC

terbutaline; inhalant

1.5

180.3

7265

29118

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

9.0

178.4

295

188

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

8.0

178.2

319

229

K30

ICD-10 Finland

Functional dyspepsia

1.5

177.8

5796

22198

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

177.7

3134

10217

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.7

177.4

420

426

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

10.8

177.2

264

141

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

177.2

1762

4679

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

176.7

11836

51992

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

176.6

5083

18915

F60.8

ICD-10 Finland

Other specific personality disorders

5.0

176.1

478

557

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

175.9

1535

3853

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

175.9

861

1588

F20

ICD-10 Finland

Schizophrenia

5.2

175.8

450

495

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

175.5

2811

27546

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

175.4

5793

22249

K08.3

ICD-10 Finland

Retained dental root

1.7

175.2

3919

13677

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

174.7

2916

28264

A11

ICPC

Chest pain NOS

1.7

174.1

3968

13917

R06AX22

ATC

ebastine; oral

1.4

173.9

9205

38837

IGV01

NOMESCO Finland

Psychiatric network contact

4.2

173.3

567

781

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

173.1

4055

14326

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

172.9

3477

11780

J01CA08

ATC

pivmecillinam; oral

1.3

172.6

20875

99796

M01AC01

ATC

piroxicam; systemic, rectal

1.5

172.0

6572

26039

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

171.7

2951

9541

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

171.6

3730

12914

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

5.2

170.6

441

490

A01AB04

ATC

amphotericin B; local oral

2.0

169.9

2203

6483

G72.8

ICD-10 Finland

Other specified myopathies

3.1

169.5

836

1549

C09AA02

ATC

enalapril; systemic

1.4

169.4

9451

40229

IGY02, ,

SPAT

3.4

169.2

721

1213

SPAT1229

SPAT

Assessment of need for aid

1.7

169.0

3615

12459

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.5

168.6

2153

22506

U07

ICPC

Urine symptom/complaint other

1.7

168.5

3537

12126

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.1

168.0

832

1546

F05.9

ICD-10 Finland

Delirium, unspecified

2.7

168.0

1042

2209

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.6

167.8

2958

28287

OAB43, ,

SPAT

0.7

167.8

10929

80645

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

167.4

12515

55867

C09CA01

ATC

losartan; oral

1.3

167.1

12790

57297

M79.1

ICD-10 Finland

Myalgia

1.5

166.9

7514

30746

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

8.6

166.4

284

190

SPAT1263

SPAT

Sampling

1.3

166.2

22913

111224

X58

ICD-10 Finland

Exposure to other specified factors

1.5

165.7

7521

30821

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

165.0

21403

103078

Z00.0

ICD-10 Finland

General medical examination

1.4

164.9

9940

42852

SFA10

NOMESCO Finland

One-surface restoration

1.3

164.9

31281

157714

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

6.0

164.8

371

356

L15

ICPC

Knee symptom/complaint

1.4

163.9

11934

53032

-1, ,

NOMESCO Finland

1.3

163.8

17809

83819

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

163.5

11555

51106

C09AA05

ATC

ramipril; oral

1.4

163.4

12149

54159

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

163.4

1081

2372

N05AE05

ATC

lurasidone; oral

7.0

163.4

325

269

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

163.2

3331

11329

R05

ICD-10 Finland

Cough

1.4

162.9

10987

48236

T74.1

ICD-10 Finland

Physical abuse

2.6

161.8

1067

2337

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.4

161.6

498

652

A02BC04

ATC

rabeprazole; oral

1.6

161.5

4465

16439

J01MA01

ATC

ofloxacin; systemic

1.6

161.4

4082

14701

XF402

NOMESCO Finland

ECG with work load test

1.6

161.4

5029

19045

G03FB05

ATC

norethisterone and estrogen; systemic

1.6

161.3

4495

16583

K92.0

ICD-10 Finland

Haematemesis

2.5

160.9

1235

2920

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

160.9

5344

20530

ZX120

NOMESCO Finland

Intravenous

1.6

160.8

4705

17559

B01AC04

ATC

clopidogrel; oral

1.4

160.7

7575

31250

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

159.6

1954

5629

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.7

158.8

455

558

N05AA03

ATC

promazine; systemic

22.8

158.6

174

G04CB01

ATC

finasteride; oral

1.5

158.6

5167

19761

P80

ICPC

Personality disorder

5.9

158.6

364

357

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

158.2

1387

16367

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

157.7

5852

23018

A12BA01

ATC

potassium chloride; oral

2.1

157.7

1852

5253

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

157.6

12162

54484

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

157.0

6616

26703

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

156.8

1759

4902

R96

ICPC

Asthma

1.6

156.5

4652

17422

C03AA03

ATC

hydrochlorothiazide; oral

1.6

156.4

4169

15209

SPAT1262

SPAT

Handing over of treatment supplies

1.4

156.2

8778

37358

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.1

155.8

1701

4690

R06AX27

ATC

desloratadine; oral

1.3

155.4

15470

71848

C08DA01

ATC

verapamil; systemic

2.0

154.4

1982

5809

R03DA04

ATC

theophylline; systemic, rectal

1.9

154.2

2429

7635

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

153.5

7674

31981

L01

ICPC

Neck symptom/complaint

1.4

153.3

7894

33073

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

153.0

1733

4847

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

153.0

5133

19752

C10AA07

ATC

rosuvastatin; oral

1.3

153.0

16157

75608

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

152.6

2068

6179

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.3

152.3

481

643

A04AA01

ATC

ondansetron; systemic, rectal

1.6

152.1

3904

14106

R01AD01

ATC

beclometasone; nasal

1.4

151.9

7943

33368

S22.3

ICD-10 Finland

Fracture of rib

1.7

151.8

3561

12573

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

151.6

5657

22267

-50

ICPC

Medication/prescr/renewal

2.0

151.5

1985

5860

D07AC13

ATC

mometasone; topical

1.3

151.5

15482

72115

R03BB01

ATC

ipratropium bromide; inhalant

2.1

151.2

1764

4990

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

151.2

1540

4129

E87.6

ICD-10 Finland

Hypokalaemia

2.1

150.9

1615

4418

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

150.5

8222

34802

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

150.3

2953

9928

KMAK, ,

NOMESCO Finland

1.2

149.8

29490

148658

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

149.5

6452

26148

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.9

149.2

408

479

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

149.2

6484

26312

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

149.2

4888

18707

SPAT1097

SPAT

Recording of ECG

1.4

149.1

6994

28797

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

149.0

3543

12552

C08CA13

ATC

lercanidipine; oral

1.4

148.8

6726

27498

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.3

148.6

1342

3419

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

148.4

4115

15150

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

9.0

148.1

246

158

P20

ICPC

Memory disturbance

1.5

148.0

5658

22376

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

147.3

4303

16040

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

5.9

146.6

335

327

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

145.9

10222

45051

N05AX15

ATC

cariprazine; oral

6.7

145.5

297

254

F60.5

ICD-10 Finland

Anankastic personality disorder

3.3

144.7

658

1157

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

10.5

144.7

218

119

ZXA10

NOMESCO Finland

Bilateral

1.4

144.5

9074

39295

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

144.1

2350

7467

R03AC12

ATC

salmeterol; inhalant

1.9

144.1

2150

6637

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

143.5

2648

8739

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

143.3

10347

45802

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

143.2

5689

22670

309

Kela drug reimbursment

Nalmefene and naltrexone

6.0

143.1

324

313

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

142.6

3010

10325

P28

ICPC

Limited function/disability (P)

3.9

142.3

507

748

UJD02

NOMESCO Finland

Gastroscopy

1.8

142.1

2272

7173

L86

ICPC

Back syndrome with radiating pain

1.7

142.1

2965

10137

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

142.0

8813

38079

C07AB03

ATC

atenolol; systemic

1.8

142.0

2556

8373

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

141.4

1916

5723

N17

ICPC

Vertigo/dizziness

1.5

141.0

5681

22696

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

140.6

2906

9908

SPAT1310

SPAT

Counselling related to known health issue

1.3

140.6

16423

77692

M01AH03

ATC

valdecoxib; oral

1.7

140.2

3025

10437

M54

ICD-10 Finland

Dorsalgia

1.4

140.2

6476

26567

K92.1

ICD-10 Finland

Melaena

1.8

139.6

2508

8210

SPAT1325

SPAT

Vaccination

1.3

139.5

16558

78476

30041

ICD-8 Finland

Neuroses, Depressiva

3.5

138.8

586

980

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

138.6

12019

54623

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

138.3

799

1628

U05

ICPC

Urination problems other

1.8

138.0

2313

7412

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

137.7

1933

5844

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

137.4

737

1438

P73

ICPC

Affective psychosis

5.3

137.2

344

371

AN1

Coronary angiography

1.5

137.0

4925

19215

R4120

NOMESCO Finland

Occupational therapy

1.7

136.7

3253

11519

C01AA05

ATC

digoxin; systemic

1.6

136.7

3420

12268

C07AG02

ATC

carvedilol; oral

1.7

136.7

2638

8820

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.2

136.6

449

621

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

136.5

5628

22581

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

136.4

1454

3970

D07AD01

ATC

clobetasol; topical

1.4

136.1

8376

36120

R52.1

ICD-10 Finland

Chronic intractable pain

3.6

136.1

533

845

SPAT1153

SPAT

Removal of sutures

1.3

136.1

16012

75757

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

136.1

11311

51079

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

4.1

135.8

460

652

A97

ICPC

No disease

1.4

135.8

8782

38174

J02AC02

ATC

itraconazole; systemic

1.4

135.6

9040

39485

I50.0

ICD-10 Finland

Congestive heart failure

1.7

135.5

3198

11300

F60.7

ICD-10 Finland

Dependent personality disorder

6.5

135.4

285

253

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

135.2

962

2191

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

135.2

2942

10173

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.6

134.7

912

2025

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

134.7

2250

7202

J01DA06

ATC

[U] cefuroxime

1.4

134.6

7295

30784

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

10193

39221

1.58

320.94

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10003

38536

1.58

312.49

2.8

2.6

22.28

23.19

7.49

8475

33097

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8792

32909

1.61

309.30

2.9

2.7

8.46

8.49

umol/l

0.03

7385

28704

(40760892) CBC W Ordered Manual Differential panel - Blood

31973

140861

1.58

307.65

7.2

6.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

8540

30952

1.67

307.65

7.4

7.5

11.98

12.66

kpa

24.49

8130

29535

(3031040) Bacteria [#/volume] in Urine by Automated count

41514

195336

1.57

307.65

5.2

4.0

1604.42

1219.25

e6/l

0.66

639

2635

(3026008) Bacteria identified in Urine by Culture

19881

83873

1.51

307.65

3.4

2.8

—

(36304419) Bacteria [Presence] in Urine

18481

77838

1.50

307.65

3.5

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13401

54228

1.52

307.65

4.1

3.5

327.23

565.38

ng/l

7.10

10008

40406

(3022096) Basophils/100 leukocytes in Blood

30749

135844

1.55

307.65

7.0

6.0

0.67

0.68

2.59

28740

127083

(3018095) Leukocytes [#/volume] in Urine

23471

102940

1.47

307.65

4.3

3.5

89.12

93.73

e6/l

0.29

17135

71907

(3013115) Eosinophils [#/volume] in Blood

34660

155048

1.58

307.65

7.3

5.9

0.19

e9/l

0.04

30600

136773

(3033658) Prothrombin time (PT) actual/Normal

17701

74678

1.49

307.65

4.7

3.8

91.25

90.81

1.35

17183

72821

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

35716

151036

1.76

307.65

7.1

5.9

10.82

11.51

umol/l

16.18

33774

143308

(3015377) Calcium [Moles/volume] in Serum or Plasma

23457

94503

1.65

307.65

3.6

3.3

2.35

mmol/l

0.40

20779

83609

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8467

29742

1.73

307.65

2.0

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

47788

234067

1.59

307.65

4.6

3.8

14.63

14.70

pmol/l

7.54

43930

214640

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14561

59462

1.52

307.65

1.7

1.6

40358038.63

34769076.81

pmol/l

0.45

12025

49838

(40758558) Short blood count panel - Blood

17721

74026

1.51

307.65

8.3

6.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12444

45005

1.72

307.65

3.8

3.4

0.81

0.82

mmol/l

14.01

11604

42262

(3013826) Glucose [Moles/volume] in Serum or Plasma

37974

172660

1.60

307.65

5.6

4.5

6.68

6.70

mmol/l

1.17

35856

160751

(3037467) Urinalysis macro (dipstick) panel - Urine

42801

207530

1.51

307.65

4.9

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

21241

85859

1.61

307.65

2.4

2.0

233.33

203.99

u/l

2.03

19924

80707

(3002582) Erythrocytes [#/volume] in Urine

20557

87353

1.50

307.65

3.7

3.1

72.04

94.44

e6/l

1.40

16074

66538

(3001604) Monocytes [#/volume] in Blood

33641

149663

1.58

307.65

6.8

5.7

0.59

0.58

e9/l

20.51

29361

130335

(3022217) INR in Platelet poor plasma by Coagulation assay

30821

132649

1.62

307.65

15.2

13.6

1.24

1.25

inr

0.96

9080

38974

(3044889) 12 lead EKG panel

42806

208903

1.48

307.65

4.1

3.5

—

(3028707) Methadone [Presence] in Urine by Screen method

2502

4193

3.52

307.65

4.1

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

18900

79717

1.50

307.65

3.5

3.0

0.42

0.41

e6/l

0.25

14661

60094

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11857

43973

1.66

307.65

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8455

29585

1.73

307.65

1.9

1.7

—

(3006315) Basophils [#/volume] in Blood

33717

149993

1.58

307.65

6.8

5.7

0.04

e9/l

0.72

29424

130468

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1038

1380

4.37

307.65

14.3

12.5

856.84

1540.15

nmol/l

0.46

1005

1329

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10696

41414

1.57

307.65

2.7

2.5

2.35

g/l

0.01

9795

38395

(3019309) Folate [Moles/volume] in Red Blood Cells

13730

49298

1.75

307.65

1.8

1.7

1173.88

1157.63

nmol/l

1.12

10450

37672

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18302

76344

1.52

307.65

3.1

2.9

1410.13

1349.63

ng/l

0.86

15422

64874

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

54693

282546

1.59

307.65

5.6

4.4

1.99

2.12

mu/l

0.78

50724

260911

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

27726

114971

1.65

307.65

2.1

1.9

96.54

95.92

pmol/l

1.18

14605

61384

(3019550) Sodium [Moles/volume] in Serum or Plasma

59368

315481

1.68

307.65

21.1

14.2

139.41

139.71

mmol/l

140.22

58162

307523

(3013650) Neutrophils [#/volume] in Blood by Automated count

37908

172860

1.59

307.65

11.4

8.6

4.19

4.10

e9/l

9.78

33410

151105

(3024666) Lithium [Moles/volume] in Serum or Plasma

1167

1169

5.81

307.65

12.8

11.6

0.62

mmol/l

0.19

1066

1082

(3019198) Lymphocytes [#/volume] in Blood

34368

154542

1.57

307.65

6.9

5.8

1.93

e9/l

0.13

30551

137516

(3009508) Creatinine [Moles/volume] in Urine

20394

90329

1.42

307.65

3.5

3.2

7.46

8.01

mmol/l

3.03

17243

76837

(3022948) Iron [Moles/volume] in Serum or Plasma

11532

45083

1.56

307.65

2.7

2.5

12.97

13.89

umol/l

1.34

10671

42189

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7416

26240

1.70

307.65

2.9

2.4

38.38

46.54

u/l

1.20

6344

22544

(3023103) Potassium [Moles/volume] in Serum or Plasma

59471

316515

1.68

307.65

21.2

14.3

3.97

3.96

mmol/l

3.07

58183

307910

(3002030) Lymphocytes/100 leukocytes in Blood

32453

145720

1.54

307.65

7.1

5.9

27.65

28.15

12.51

30513

137343

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10052

36051

1.71

307.65

6.4

6.0

1.04

mmol/l

0.47

9409

33695

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

31252

126875

1.77

307.65

6.8

5.9

1.21

mmol/l

1.45

28746

115983

(3011288) Drugs identified in Urine by Screen method

3006

7300

2.43

307.65

5.0

2.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5877

19428

1.81

307.65

1.7

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

23029

91069

1.69

307.65

3.0

2.5

58.36

62.42

u/l

1.58

21228

84360

(3023368) Bacteria identified in Blood by Culture

19395

75129

1.68

307.65

5.0

4.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

16478

62458

1.68

307.65

1.6

1.5

20.68

20.05

nmol/l

5.23

14335

53902

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24365

97854

1.67

307.65

3.8

3.1

35.02

33.21

u/l

1.40

23046

92956

(3013707) Erythrocyte sedimentation rate by Westergren method

46067

224245

1.57

307.65

4.5

3.9

12.43

11.45

mm/h

37.17

42753

208659

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

33981

140705

1.78

307.65

7.7

6.5

1.21

mmol/l

1.90

29009

119524

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17837

70605

1.61

307.65

2.4

2.2

2.94

2.91

mg/l

0.76

15233

60548

(3018418) pH of Serum or Plasma

21049

82256

1.68

307.65

4.6

4.0

7.40

0.83

4029

15805

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

42099

210399

1.40

307.65

4.0

2.9

55.81

45.94

u/l

60.66

39340

197963

(3018010) Neutrophils/100 leukocytes in Blood

31965

143565

1.53

307.65

6.8

5.8

57.43

57.13

4.05

30005

135243

(3009466) Valproate [Moles/volume] in Serum or Plasma

2309

3215

4.23

307.65

6.0

4.5

379.34

361.38

umol/l

5.15

2046

2753

(3006504) Eosinophils/100 leukocytes in Blood

31660

140415

1.56

307.65

7.0

5.9

2.80

2.87

5.77

29662

131779

(3001122) Ferritin [Mass/volume] in Serum or Plasma

29143

132158

1.47

307.65

3.2

2.8

130.84

123.16

ug/l

3.31

26956

123444

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7523

25841

1.76

307.65

2.3

2.2

365.90

373.70

nmol/l

2.51

6924

23897

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

49238

229747

1.86

307.65

9.0

7.1

78.70

77.44

u/l

6.32

46667

216947

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27694

120151

1.55

307.65

2.4

2.2

77.35

828.78

nmol/l

0.50

25172

108961

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8549

30967

1.67

307.65

7.4

7.5

5.13

5.08

kpa

4.83

8135

29560

(3019069) Monocytes/100 leukocytes in Blood

31816

141242

1.56

307.65

7.3

6.2

8.55

8.51

0.96

29867

132765

(3000850) Epithelial cells [#/volume] in Urine

14789

60031

1.53

307.65

2.9

2.5

5.80

5.43

e6/l

1.89

13306

53713

(3003396) Base excess in Arterial blood by calculation

8546

30981

1.67

307.65

7.5

1.16

0.98

mmol/l

3.34

6874

24616

(3026782) Osmolality of Urine

14192

56624

1.56

307.65

3.2

2.8

521.15

551.34

mosm/kgh2o

39.56

12247

48599

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

24815

108430

1.50

307.65

4.0

3.3

56.50

65.14

ng/l

0.32

16821

69897

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12566

50154

1.54

307.65

3.1

3.0

2.45

mmol/l

2.55

10950

43811

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11329

36783

1.92

307.65

2.2

1.7

1.55

1.41

57.96

9874

32754

(3024561) Albumin [Mass/volume] in Serum or Plasma

29934

123507

1.70

307.65

5.3

4.7

35.46

35.75

g/l

14.12

27819

114818

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1095

1451

4.39

307.65

19.4

17.8

2366.43

2948.73

nmol/l

0.16

1057

1386

(3042936) Bacteria identified in Isolate by Culture

10404

40800

1.55

299.43

2.2

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

53348

279876

1.45

298.23

6.3

5.3

39.63

39.46

mmol/mol

3.62

49531

260796

(3036180) Methadone [Presence] in Urine

845

1030

4.76

296.76

2.5

2.3

—

(3016502) Oxygen saturation in Arterial blood

7610

27760

1.65

295.40

7.8

7.9

95.41

95.78

4.88

7342

26698

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7185

25925

1.66

290.51

2.4

2.3

0.22

0.21

g/l

1.72

6636

24162

(1001926) Buprenorphine [Presence] in Urine by Screen method

3152

8716

2.13

289.10

3.8

1.9

—

(3021589) Normoblasts [#/volume] in Blood

28208

133875

1.36

286.78

11.4

9.0

0.00

e9/l

0.16

23181

110041

(3014111) Lactate [Moles/volume] in Serum or Plasma

6726

24114

1.67

277.81

7.2

7.3

1.38

1.35

mmol/l

1.19

6513

23540

(3027945) Reticulocytes/100 erythrocytes in Blood

8041

30176

1.60

277.36

2.6

2.5

1.82

1.73

10.51

7059

26835

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

58126

311430

1.53

274.17

18.9

12.6

23.28

23.33

mg/l

0.12

48527

243573

(3020779) Urea [Moles/volume] in Serum or Plasma

6782

24475

1.66

272.90

8.0

7.7

9.61

9.67

mmol/l

0.28

6462

23304

(3007853) Bacteria identified in Skin by Aerobe culture

8830

34546

1.54

252.50

1.9

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15102

65751

1.41

250.84

1.9

1.7

1.15

1.18

mg/l

0.44

11467

49990

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6945

25737

1.61

250.30

8.3

121.34

122.25

g/l

2.87

6764

25029

(3015736) pH of Urine

25280

119833

1.34

246.13

3.7

3.1

5.89

5.85

1.27

1851

10102

(3023183) Ammonium ion [Moles/volume] in Plasma

2154

5435

2.32

244.69

2.9

2.7

34.31

33.86

umol/l

0.28

1963

4926

(3002032) Base excess in Venous blood by calculation

6817

25318

1.61

243.03

4.6

3.9

1.79

1.84

mmol/l

0.37

5794

21561

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6828

25419

1.60

240.94

4.6

3.9

5.86

5.81

kpa

3.08

6574

24733

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11022

45577

1.46

240.29

3.2

2.8

2.95

2.74

e6/l

1.02

6030

24515

(3000991) Gas panel - Venous blood

6331

23147

1.63

240.23

8.8

8.7

—

(3012544) pH of Venous blood

7013

26355

1.59

237.77

4.5

3.9

7.38

0.20

202

(3035350) Ketones [Presence] in Urine by Test strip

30391

148462

1.32

236.98

4.1

3.4

0.00

estimate

0.72

6389

29272

(3009261) Glucose [Presence] in Urine by Test strip

30647

150020

1.32

234.57

4.1

3.4

0.00

estimate

1.91

5939

27023

(3021601) Nitrite [Presence] in Urine by Test strip

30354

148431

1.32

233.73

5.4

4.6

0.00

estimate

0.98

6130

27900

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10602

43775

1.46

231.94

2.2

2.1

29.85

29.81

0.29

10251

42552

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3976

12907

1.82

230.14

4.8

4.4

24.07

24.09

mmol/l

0.15

3847

12658

(3016879) Cocaine [Presence] in Urine

3469

10783

1.89

229.72

3.7

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11623

49058

1.43

225.73

3.0

2.7

1.34

1.10

e6/l

0.46

6607

27790

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

8055

31772

1.52

219.17

4.3

4.2

237.83

243.86

u/l

2.98

7584

30099

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

607

722

4.86

218.83

2.4

2.5

149.92

151.01

nmol/l

0.06

522

639

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

693

937

4.28

216.44

2.2

1.8

126.97

140.25

umol/l

0.37

340

467

(3044640) Blood type and Crossmatch panel - Blood

20223

94256

1.33

211.79

2.7

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

55344

296802

1.40

210.54

5.1

4.2

5.98

5.89

mmol/l

51.37

50779

273538

(3023520) Reticulocytes [#/volume] in Blood

5961

22246

1.59

206.24

2.6

71.55

68.99

e9/l

5.26

4452

16788

(3019060) Gas panel - Arterial blood

4951

17660

1.66

205.15

5.1

4.8

—

(3000764) Benzodiazepines [Presence] in Urine

3592

11697

1.81

205.11

3.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

3604

11802

1.80

201.98

3.8

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4889

17457

1.65

201.62

3.9

3.6

5.16

5.13

kpa

1.52

4654

16497

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1081

2110

2.97

201.39

1.7

1.4

1.46

1.36

promille

1.00

839

1628

(3042517) Benzodiazepines panel - Urine

318

190

9.65

200.09

3.3

2.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4432

15450

1.69

199.91

1.8

1.6

—

(3027008) Opiates [Presence] in Urine

3587

11772

1.79

199.52

3.7

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

18983

88296

1.33

198.54

3.9

10.35

9.08

mg/mmol

2.21

11870

56593

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2991

9294

1.89

197.56

2.4

2.3

523.89

542.31

ug/l

0.08

2793

8697

(3009343) pH of Capillary blood

4818

17244

1.65

196.69

3.9

3.6

7.41

7.42

0.48

682

2202

(3012516) Albumin [Mass/volume] in Urine

18097

83846

1.33

193.33

3.4

3.3

522.73

380.91

mg/l

2.92

11487

54089

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4667

16652

1.65

192.64

3.9

3.5

1.68

1.62

mmol/l

0.44

3461

12201

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1244

16309

0.43

189.98

1.4

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1954

5279

2.16

188.61

1.5

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4725

17020

1.64

187.78

7.0

7.6

24.84

24.70

mmol/l

1.68

4685

16865

(3024354) Oxygen [Partial pressure] in Venous blood

5549

20841

1.58

185.83

3.8

3.3

4.78

4.61

kpa

5.44

5296

20209

(3026493) Urate [Moles/volume] in Serum or Plasma

17154

79230

1.33

185.65

2.8

2.5

3402.75

4180.84

umol/l

1.97

14889

70302

(3007164) IgA [Mass/volume] in Serum or Plasma

13091

58106

1.36

184.22

1.5

1.4

2.43

2.39

g/l

1.04

7833

36370

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

28787

142589

1.28

183.21

2.8

2.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

54288

291771

1.35

182.76

16.9

11.7

82.15

83.40

ml/min/173m2

32.58

45852

240536

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4504

16145

1.64

182.21

1.6

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4078

14241

1.68

182.14

9.1

9.9

24.27

24.29

mmol/l

0.11

3920

13779

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2552

7765

1.92

179.08

1.4

276.17

274.80

ug/g

0.09

1474

4468

(3013512) EKG study

17689

82411

1.31

178.62

4.2

3.6

—

(3048689) Calprotectin [Mass/mass] in Stool

8856

36971

1.43

177.77

2.3

2.4

138.06

130.75

ug/g

0.80

6991

29428

(3020630) Protein [Mass/volume] in Serum or Plasma

5745

21965

1.55

177.62

2.8

2.5

66.27

66.67

g/l

3.35

5210

20055

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5787

22169

1.55

177.34

3.0

2.8

200.05

199.19

ng/l

0.04

5263

20087

(3000494) Fungus identified in Specimen by Culture

8254

34034

1.45

176.98

1.5

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14725

66949

1.34

175.72

1.3

1.34

1.77

u/ml

4.76

3796

18742

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5351

20192

1.57

175.09

4.1

4.0

94.82

90.78

ng/l

1.79

4674

17531

(3027944) Amphetamines [Presence] in Urine

3454

11642

1.74

174.93

3.5

1.7

—

(3022145) Colonoscopy Study observation

8013

32947

1.45

174.15

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7073

28414

1.48

173.02

3.9

3.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16620

77345

1.31

166.77

1.7

1.6

1.50

1.36

mmol/l

43.06

14054

65377

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5918

23170

1.51

163.38

2.5

2.1

12.76

12.46

nmol/l

1.94

5215

20970

(3003181) Sodium [Moles/volume] in Urine

1552

4050

2.23

162.64

1.4

59.80

64.85

mmol/l

4.38

1202

3219

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4579

17001

1.59

159.90

7.7

7.1

24.76

24.51

mmol/l

4.19

4367

16160

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15385

71433

1.31

154.75

2.6

2.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4893

18634

1.55

152.81

3.2

3.4

4.39

4.53

pmol/l

14.66

4278

16770

(3011397) Hemoglobin [Presence] in Urine by Test strip

14792

68482

1.31

151.36

3.9

3.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4702

17847

1.55

148.86

2.6

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

693

1238

3.24

148.80

2.0

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

5590

22038

1.50

148.53

2.8

2.6

10.41

10.61

g/l

2.31

5106

20203

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3438

12128

1.66

146.89

1.7

1.57

1.52

g/l

2.46

2953

10341

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4567

17296

1.55

145.90

9.2

9.5

1.45

1.37

5.04

4540

17176

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4036

14887

1.59

144.31

9.7

10.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4554

17283

1.55

144.06

9.4

9.6

0.67

0.68

0.65

4529

17174

(3014007) Fractional oxyhemoglobin in Arterial blood

4569

17357

1.55

143.90

9.4

9.6

93.57

94.00

4.56

4547

17301

(3017143) Hepatitis C virus Ab [Presence] in Serum

8449

36214

1.39

143.04

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

4506

17097

1.55

142.63

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

9576

41928

1.36

142.14

1.4

1.3

482.43

550.85

titre

2.89

1859

8462

(40768804) Tissue Pathology biopsy report

24900

123697

1.25

141.20

2.2

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5702

22836

1.47

139.75

4.5

3.7

1.22

1.23

mmol/l

1.51

4973

20013

(3019150) Specific gravity of Urine by Refractometry

13824

64175

1.30

136.13

4.5

3.7

1.02

kg/l

0.50

1941

9803

(3017181) Myelocytes/100 leukocytes in Blood

6023

24563

1.45

134.15

4.5

4.1

0.99

0.95

0.45

2228

8023

(3050129) First trimester maternal screen panel - Serum or Plasma

836

10943

0.43

125.88

1.4

—

(21494755) Public health laboratory ask at order entry panel

4472

36730

0.68

125.08

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

5491

22382

1.44

121.98

4.3

3.9

0.72

0.68

0.45

1917

6934

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2250

7421

1.77

121.90

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

4372

17040

1.51

121.60

2.0

1.8

1.27

1.32

g/l

1.03

3977

15592

(4200892) Spirometry reversibility

5115

20610

1.46

120.64

1.5

1.4

—

(3022313) Gas panel - Capillary blood

3392

12520

1.58

120.28

4.1

3.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

754

1619

2.69

118.74

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1826

5690

1.87

118.73

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1825

5689

1.86

118.53

1.4

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

16524

79548

1.25

118.17

4.6

3.7

0.00

estimate

0.40

5899

26738

(3020564) Creatinine [Moles/volume] in Serum or Plasma

60027

331707

1.36

118.07

21.3

14.5

78.23

76.69

umol/l

18.71

60013

331546

(3021440) Promyelocytes/100 leukocytes in Blood

5676

23428

1.43

117.61

4.5

4.1

0.11

0.12

0.05

1886

6935

(3002385) Erythrocyte distribution width [Ratio]

50151

270880

1.25

117.43

22.5

14.9

15.11

14.99

0.42

49435

266034

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

60172

332874

1.36

114.07

13.1

9.5

27.71

26.66

u/l

12.15

58386

321963

(3010421) pH of Blood

2183

7294

1.74

113.04

4.3

3.8

7.42

0.51

1977

6682

(3025159) Blasts/100 leukocytes in Blood

5398

22251

1.43

112.40

4.6

4.1

0.14

0.38

2.50

1606

5841

(3019225) pH of Specimen

6456

27526

1.38

110.59

4.8

3.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

559

8166

0.39

109.99

1.4

1.5

—

(1616796) Gas panel - Central venous blood

1916

6221

1.79

109.26

3.8

3.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2069

6882

1.75

108.77

3.1

3.0

24.61

24.62

mmol/l

0.02

2021

6730

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5590

23360

1.41

107.56

2.5

2.2

6.79

7.65

ug/l

1.76

4812

20500

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6611

28473

1.37

106.15

4.0

21.66

26.11

ug/l

0.57

5404

22653

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

592

1192

2.87

104.70

1.9

1.5

2712746.80

1318285.46

iu/ml

1.59

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

23016

116002

1.21

103.02

4.3

3.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

742

9364

0.45

101.12

1.3

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11338

53040

1.27

100.51

1.3

36.87

34.32

iu/ml

0.22

3479

17295

(3008295) Osmolality of Serum or Plasma

937

2430

2.23

99.56

1.5

279.73

280.27

mosm/kgh2o

0.24

707

1927

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2509

9012

1.62

99.11

2.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1904

6350

1.74

99.10

4.3

3.8

5.03

4.98

kpa

1.62

1864

6200

(42529406) Shigella sp [Presence] in Stool by Culture

2358

8338

1.65

99.06

1.2

—

(3012501) Base excess in Blood by calculation

1903

6349

1.74

98.92

4.3

3.8

2.48

2.45

mmol/l

0.16

1326

4235

(3027315) Oxygen [Partial pressure] in Blood

1912

6390

1.74

98.80

4.4

3.9

8.63

8.67

kpa

0.49

1872

6239

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1866

6195

1.75

98.66

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2333

8241

1.65

98.40

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2348

8322

1.64

97.74

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1911

6427

1.73

96.58

1.7

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1909

6438

1.72

95.54

3.5

3.4

8.27

8.36

kpa

1.47

1860

6287

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2851

10677

1.56

94.48

2.2

2.0

2.26

2.13

ug/l

0.20

2527

9426

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2914

10972

1.55

94.30

4.5

3.9

24.76

mmol/l

0.03

2728

10162

(3052851) Hemolysis interference index of Serum or Plasma

2374

8539

1.62

93.17

3.4

3.0

—

(3047181) Lactate [Moles/volume] in Blood

2424

8778

1.61

92.56

6.2

5.6

1.34

1.30

mmol/l

0.92

2146

7759

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2697

10021

1.57

92.46

2.5

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2692

10005

1.57

92.18

2.5

2.2

3.66

3.74

g/l

1.77

2419

9041

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

717

8860

0.46

92.16

1.3

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

245

281

5.02

92.02

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

717

8855

0.46

92.01

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

715

8838

0.46

91.98

1.3

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1573

5067

1.80

91.97

1.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

1766

5889

1.74

91.91

2.7

2.4

16.49

16.58

0.31

948

3019

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2697

10036

1.56

91.85

2.5

2.2

7.32

7.37

g/l

0.76

2419

9065

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

714

8806

0.46

91.28

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2555

9415

1.58

90.72

2.6

2.2

2.91

2.93

g/l

0.33

2278

8447

(3024928) Oxygen saturation in Venous blood

1708

5674

1.75

90.06

3.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1888

6465

1.70

89.41

2.1

1.9

201.33

197.12

pmol/l

0.84

1776

6155

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2530

9347

1.58

88.83

2.5

2.2

9.91

10.27

g/l

3.34

2236

8323

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

535

7247

0.42

87.56

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3650

14635

1.46

87.23

2.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19311

96839

1.20

87.06

5.0

4.6

2.77

3.28

ug/l

1.83

17138

87467

(3021901) Oxygen saturation in Capillary blood

1540

5013

1.78

86.97

2.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2663

10011

1.55

86.65

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2322

8463

1.60

86.27

2.6

2.3

0.83

0.86

g/l

0.12

1972

7300

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

379

5903

0.36

86.12

1.3

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10593

49992

1.26

85.46

1.3

10.25

11.68

u/ml

1.03

3881

20154

(3004119) Hemoglobin [Mass/volume] in Venous blood

4066

16765

1.42

83.49

3.9

3.3

128.12

129.94

g/l

5.32

3968

16387

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3244

12833

1.47

82.94

3.5

2.9

1.39

1.27

6.08

3225

12768

(3018405) Lactate [Moles/volume] in Arterial blood

2534

9530

1.55

82.24

4.5

4.2

1.41

1.37

mmol/l

0.74

2487

9367

(3028271) Lactate [Moles/volume] in Capillary blood

1358

4360

1.80

80.24

2.1

1.8

1.72

1.75

mmol/l

0.60

1330

4253

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2163

7899

1.59

79.64

3.8

3.1

5.90

2.81

ratio

0.56

183

616

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2124

7726

1.60

79.50

2.4

2.2

37.75

37.87

g/l

0.36

1843

6739

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2426

9111

1.55

79.19

3.3

3.2

0.33

0.35

u/ml

1.44

1370

5170

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2212

8133

1.58

79.15

3.9

3.1

48.19

42.08

mg/l

0.48

1793

6559

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2454

9250

1.54

78.80

1.9

1.7

39.76

41.05

nmol/l

1.80

2376

9044

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2265

8385

1.57

78.72

1.8

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1455

4798

1.76

78.65

1.1

—

(40761511) CBC panel - Blood by Automated count

58780

326522

1.26

78.14

17.5

11.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3159

12578

1.46

78.05

3.5

2.9

0.64

0.66

1.55

3143

12530

(3043238) Trisomy 21 risk [Likelihood] in Fetus

601

7457

0.46

78.03

1.3

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2209

8148

1.57

77.97

3.9

3.1

54.92

64.48

mg/l

0.47

1792

6567

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2066

7525

1.59

76.88

2.5

2.2

0.04

0.03

g/l

0.29

1866

6898

(3023419) Bacteria identified in Sputum by Culture

1232

3890

1.83

76.79

2.5

2.4

—

(36660697) Celiac disease serology panel - Serum

5426

23774

1.34

76.45

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

586

7272

0.46

76.11

1.3

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1929

6928

1.62

76.02

2.4

2.2

0.00

g/l

0.02

1733

6325

(3005033) Fetal Nuchal fold Thickness US

586

7261

0.46

75.79

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7697

35447

1.28

75.12

8.1

6.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2878

11336

1.48

75.04

5.7

4.9

1.80

1.68

6.35

2688

10637

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1690

5888

1.66

74.98

5.7

5.9

3266.95

1261.94

iu/ml

0.35

240

883

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1724

6044

1.65

74.70

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

2205

8222

1.56

74.23

1.2

119.90

122.82

titre

0.04

206

752

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1900

6840

1.61

74.16

2.5

2.3

0.00

g/l

-0.00

1727

6309

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1791

6358

1.63

73.92

2.3

2.1

129.97

131.26

g/l

1.14

1297

4666

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1427

4765

1.73

73.88

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1144

3600

1.84

72.08

6.2

6.3

11.34

11.38

mg/l

0.10

1043

3318

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3113

12558

1.44

71.72

1.5

13.87

14.34

u/ml

0.05

348

(3007930) Methemoglobin/Hemoglobin.total in Blood

2808

11153

1.46

70.11

5.7

4.9

0.91

0.89

1.07

2625

10464

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1377

4635

1.72

69.31

1.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

16361

82165

1.19

68.85

3.7

3.0

—

(3039000) Anion gap in Blood

1699

6066

1.62

68.53

7.2

6.7

11.16

11.27

mmol/l

0.64

1539

5458

(3018572) Chloride [Moles/volume] in Blood

1699

6067

1.62

68.49

7.2

6.7

104.84

105.23

mmol/l

2.31

1539

5460

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5273

23430

1.32

66.97

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

2137

8108

1.53

66.51

1.2

770.38

967.27

titre

0.71

245

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

56437

313092

1.21

66.08

5.3

4.5

2.71

2.81

mmol/l

121.47

52212

291800

(3037756) Immunofixation for Serum or Plasma

1523

5350

1.65

65.47

1.9

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1319

4459

1.71

65.38

2.8

2.9

8895.74

5305.20

u/ml

0.17

243

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1386

4770

1.68

64.38

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

1685

6101

1.60

64.21

4.0

3.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1624

5833

1.61

63.94

1.5

—

(3020891) Body temperature

2727

10984

1.44

63.20

5.6

4.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1303

4438

1.70

62.88

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1303

4439

1.70

62.83

1.7

—

(3016038) Potassium [Moles/volume] in Urine

589

1531

2.22

62.43

1.2

32.63

35.09

mmol/l

1.54

495

1336

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2882

11807

1.42

60.87

1.1

1.57

11.31

u/ml

2.00

186

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

175

217

4.64

60.69

7.4

7.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

1084

3552

1.76

59.91

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

2134

8290

1.49

59.39

4.9

4.5

3.86

3.89

mmol/l

1.45

2118

8216

(1002224) Polysomnography panel

3202

13426

1.39

59.12

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1750

6525

1.55

58.85

1.4

1.5

1733.68

2243.97

e6/l

0.26

1443

5286

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1748

6520

1.55

58.69

1.4

28.60

30.19

e6/l

0.06

1364

5030

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

55504

308183

1.19

57.82

4.8

4.1

4.61

4.71

mmol/l

80.45

51485

288827

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1937

7415

1.51

57.81

1.3

1.4

519.13

547.86

mg/l

0.69

1846

7082

(3022806) Fractional oxyhemoglobin in Capillary blood

1075

3560

1.74

57.32

2.0

1.8

89.21

90.03

3.82

1061

3505

(3007463) Buprenorphine [Presence] in Urine

104

7.76

57.09

9.4

7.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1634

6056

1.56

56.41

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1094

3660

1.73

56.31

1.6

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3555

15301

1.35

55.71

3.2

2.6

0.28

e6/l

0.02

3457

14873

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

53376

295611

1.18

55.45

4.3

3.7

1.40

1.28

mmol/l

193.45

48875

274262

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2446

9914

1.43

54.72

1.6

188.85

294.60

titre

1.72

413

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1179

4078

1.67

53.79

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1633

6125

1.54

53.49

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2296

9242

1.44

53.30

1.4

9.76

10.00

u/l

0.35

1827

7599

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4457

32371

0.78

52.82

1.8

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

55067

306064

1.18

52.54

4.7

4.1

1.43

1.46

mmol/l

38.10

50847

285647

(40761535) Cells panel - Urine sediment

5160

23589

1.28

52.23

3.8

3.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2020

7968

1.47

52.09

1.5

17.61

13.88

iu/ml

0.42

187

(4035726) Immunohistochemistry procedure

5498

25358

1.27

51.73

1.4

—

(3017732) Neutrophils [#/volume] in Blood

4669

21111

1.29

51.51

3.4

2.6

4.82

4.93

e9/l

0.21

3745

17300

(3026389) Candida sp identified in Specimen by Organism specific culture

1167

4075

1.65

51.37

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1038

3524

1.70

50.74

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

270

3863

0.40

50.58

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3124

13376

1.36

50.53

4.1

3.4

25.28

25.21

mmol/l

0.55

3030

12965

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

759

2357

1.86

49.97

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1705

6553

1.51

49.93

1.3

3.80

3.74

mmol/l

1.05

1588

6173

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2374

9730

1.41

49.90

1.4

—

(3049717) Cytology report of Urine Cyto stain

2531

10504

1.40

49.53

2.5

2.7

—

(40761536) Microorganisms panel - Urine sediment

5508

25550

1.26

49.26

4.6

3.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4415

19931

1.29

49.23

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2683

11274

1.38

48.76

1.7

1.6

347.43

298.89

mu/l

4.96

2400

10228

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

15100

77079

1.16

48.54

4.4

4.0

21.68

22.01

1.58

6623

36193

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2833

12021

1.37

48.49

1.2

0.82

0.84

u/ml

0.03

247

1052

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

912

3033

1.74

47.99

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

912

3035

1.73

47.89

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2218

9061

1.42

47.47

1.7

0.23

g/l

0.15

2110

8588

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2369

9827

1.40

46.46

3.4

3.5

2034.74

1803.43

u/ml

0.07

2034

8451

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2269

9344

1.41

46.41

1.7

1.19

1.18

g/l

0.74

2164

8890

(3023323) Follitropin [Units/volume] in Serum or Plasma

3669

16296

1.31

46.12

1.4

1.3

28.13

27.90

iu/l

0.15

3117

14129

(3004809) Band form neutrophils/100 leukocytes in Blood

1232

4490

1.59

45.74

3.2

1.50

1.54

0.14

1111

3990

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2613

11048

1.37

45.70

1.6

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2554

10792

1.37

44.82

2.0

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1963

7927

1.43

44.76

3.5

3.6

1.59

1.50

mg/l

4.38

1816

7319

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2765

11855

1.35

44.25

2.2

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

866

2913

1.72

43.83

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4589

21116

1.27

43.72

2.4

24.46

22.16

au/ml

0.75

346

1751

(3040151) Glucose [Moles/volume] in Capillary blood

911

3110

1.69

43.71

16.7

5.6

7.55

7.32

mmol/l

0.48

763

2534

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1063

3784

1.62

43.47

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

774

2530

1.76

43.27

3.0

2.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2928

12718

1.34

42.99

2.0

39.00

39.39

u/l

0.46

2592

11386

(40768443) Skin Pathology biopsy report

2947

12822

1.33

42.78

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1958

7972

1.42

42.69

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2856

12379

1.34

42.53

4.7

3.8

50.76

48.01

6.88

2816

12246

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1388

5285

1.52

42.49

3.5

3.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

890

3046

1.69

42.33

1.7

1.6

—

(3019230) Fractional oxyhemoglobin in Venous blood

1275

4772

1.54

42.21

3.8

3.2

64.14

65.20

0.89

1267

4751

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1000

3543

1.63

41.68

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1021

3637

1.62

41.66

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

998

3555

1.62

40.73

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

2321

9807

1.37

40.72

3.3

3.2

0.31

0.32

g/l

0.11

1097

4408

(3005988) Vibrio sp identified in Specimen by Organism specific culture

987

3514

1.62

40.37

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

984

3512

1.62

39.86

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

1014

3648

1.60

39.77

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

983

3510

1.62

39.75

1.5

1.4

—

(3000012) Reticulocyte production index

1023

3693

1.60

39.57

2.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4191

19307

1.26

39.41

1.3

47.84

52.13

au/ml

0.56

198

996

(3005322) IgE [Units/volume] in Serum or Plasma

4233

19540

1.26

39.12

1.4

1.3

248.54

236.96

u/ml

0.16

3899

18168

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1178

4408

1.54

39.07

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

943

3352

1.62

38.84

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

749

2514

1.72

38.27

3.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

781

2666

1.69

37.56

1.7

—

(3002256) Pathology report gross observation

8027

39678

1.18

37.36

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2962

21713

0.77

37.19

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

638

2064

1.78

37.01

1.6

1.5

—

(3023410) Appearance of Cerebral spinal fluid

845

2969

1.64

36.46

1.5

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

7.03

36.35

1.4

429.93

577.23

nmol/l

0.88

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

792

2750

1.66

35.77

1.6

1.5

—

(3019977) pH of Arterial blood

480

1434

1.93

35.65

2.8

2.4

7.42

0.11

156

507

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1615

6590

1.42

34.81

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3455

15783

1.27

34.75

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

410

1172

2.01

34.48

2.7

2.3

55.43

51.37

umol/l

1.49

352

1010

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5051

24115

1.22

34.07

2.7

2.6

67.01

67.24

ml/min/173m2

0.14

2061

9339

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10908

55611

1.15

33.74

3.0

2.9

0.70

0.78

ug/l

9.97

7215

35450

(3024980) IgG subclass 4 [Mass/volume] in Serum

1241

4851

1.48

33.57

1.5

1.6

0.71

0.77

g/l

0.98

951

3637

(3036489) Thrombin time

2598

11492

1.31

33.50

2.1

21.41

21.53

0.39

2287

9937

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

576

1863

1.78

33.50

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2119

9103

1.35

33.45

2.8

2.7

3.62

3.61

g/l

0.09

2005

8701

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1119

4295

1.50

33.08

1.6

—

(3051651) Icteric interference index of Serum or Plasma

520

1640

1.83

32.83

4.1

3.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4497

21298

1.23

32.78

1.2

112.47

149.43

iu/ml

8.64

1557

8235

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

987

3695

1.54

32.75

1.6

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1477

6011

1.42

32.33

3.5

3.3

4.18

4.11

e9/l

0.65

1470

6002

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

680

2332

1.68

32.24

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

680

2332

1.68

32.24

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

680

2332

1.68

32.24

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

566

1848

1.76

31.93

1.8

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

11500

59039

1.14

31.92

2.0

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

406

1190

1.96

31.92

2.1

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1264

5010

1.46

31.88

1.4

1.3

27.09

26.57

u/l

0.20

998

4151

(3004716) Salmonella sp identified in Stool by Organism specific culture

3334

15341

1.26

31.52

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

2898

13141

1.28

30.91

2.0

1.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

188

2542

0.42

30.88

1.5

1.6

8.49

7.77

mmol/l

3.45

183

2437

(3008757) Leukocyte morphology finding [Identifier] in Blood

825

3008

1.58

30.74

3.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

726

2578

1.62

30.15

2.2

38.55

38.58

0.01

709

2533

(3013005) Retinol [Moles/volume] in Serum or Plasma

395

1174

1.94

29.89

1.7

1.9

2.01

1.95

umol/l

0.74

372

1103

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1043

4053

1.48

29.11

1.3

1.05

1.22

nmol/l

0.12

1001

3910

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1039

4042

1.48

28.85

1.3

0.16

0.27

nmol/l

2.89

236

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1476

6144

1.39

28.42

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

861

3229

1.54

28.41

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

827

3079

1.55

28.20

1.5

3972.70

3099.19

e6/l

0.31

613

2233

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1145

4571

1.45

27.88

3.1

3.0

0.82

0.80

nmol/l

0.47

846

3519

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

330

944

2.01

27.83

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

777

2862

1.56

27.77

2.4

1.21

e9/l

0.02

683

2570

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1395

5775

1.39

27.75

1.3

279.03

267.32

u/ml

0.80

942

3753

(3017354) Segmented neutrophils/100 leukocytes in Blood

748

2733

1.58

27.68

3.2

3.3

56.54

57.34

0.44

646

2302

(3011985) Renin [Units/volume] in Plasma

1011

3947

1.48

27.60

1.5

1.6

65.49

65.90

mu/l

0.02

870

3570

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2129

9425

1.31

27.30

1.8

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1615

6874

1.36

27.11

1.6

14467.81

13220.10

e6/l

0.44

1142

5043

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

612

2144

1.64

26.87

2.4

2.6

717.14

689.98

e6/l

0.36

582

2086

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

937

3623

1.49

26.84

2.1

1.8

3883.39

4008.53

titre

0.03

150

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1379

5733

1.39

26.77

1.2

203.85

111.93

titre

0.43

114

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

804

3011

1.54

26.74

1.2

65.51

62.98

u/l

0.27

711

2723

(21494890) Protein electrophoresis panel - 24 hour Urine

747

2752

1.56

26.70

2.5

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1861

8117

1.32

26.55

2.0

2.1

11.21

10.79

mg/l

0.99

1723

7615

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

506

1690

1.72

26.51

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4750

32009

0.84

26.36

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

895

3443

1.50

26.29

1.4

1.5

33.33

33.07

g/l

0.23

816

3091

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

371

1129

1.89

26.28

2.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

497

1659

1.72

26.10

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1471

6211

1.37

26.00

1.2

38.44

43.49

u/ml

0.52

139

628

(3017569) Oxygen content in Arterial blood

378

1163

1.87

25.92

2.2

2.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

183

2326

0.45

25.68

1.3

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

561

1948

1.66

25.52

1.7

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

811

3078

1.52

25.41

1.3

1.4

2.82

3.03

g/l

2.80

581

2120

(4062490) Immunoglobulin typing, IgG

812

3085

1.52

25.32

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

809

3078

1.51

25.06

1.3

1.4

0.37

0.41

g/l

1.82

580

2129

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

119

218

3.14

25.06

1.3

1.2

52.02

44.42

mg/l

0.74

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1478

6285

1.36

24.99

1.4

1.5

16.40

19.06

u/ml

0.34

122

(3027135) IgG subclass 1 [Mass/volume] in Serum

809

3084

1.51

24.84

1.3

1.4

6.55

6.83

g/l

1.05

577

2125

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7099

35805

1.15

24.83

4.7

4.3

31.81

32.06

1.04

4990

25476

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1487

6340

1.35

24.73

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

744

2791

1.54

24.60

1.5

70526.58

52506.32

e6/l

0.58

453

1675

(3006922) Hepatitis E virus Ab [Presence] in Serum

588

2089

1.62

24.49

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

935

3685

1.46

24.40

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2164

9749

1.28

24.32

2.3

2.4

92.32

92.40

0.05

2068

9357

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1899

8413

1.30

24.25

1.3

38.30

35.31

u/ml

0.15

101

519

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1077

4367

1.42

24.18

4.1

3.4

32.78

37.29

u/ml

0.53

1041

4217

(3000492) Spirometry study

6227

31165

1.16

24.14

1.5

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.66

24.08

1.7

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

540

1886

1.65

24.06

1.4

12.34

12.73

u/l

0.66

519

1826

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

851

3306

1.48

23.89

2.0

1.9

26.45

23.68

ug/l

0.43

829

3248

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

780

2.03

23.82

3.1

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

780

2.03

23.82

3.1

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1989

8889

1.29

23.79

2.6

192.86

185.00

3.29

1867

8444

(1761868) Lipid panel - Serum or Plasma

19275

118186

0.91

23.71

3.0

2.7

—

(3044941) Cell count panel - Synovial fluid

1076

4384

1.42

23.53

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

654

2409

1.56

23.47

1.2

133.76

196.25

titre

1.44

101

400

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

364

1144

1.83

23.43

1.7

1.8

28.60

29.27

umol/l

0.62

357

1097

(3029634) Reagin Ab [Titer] in Serum by VDRL

1070

4359

1.42

23.42

2.6

2.1

6.04

7.50

titre

0.23

118

(3045788) Cell count panel - Pleural fluid

643

2363

1.57

23.31

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

651

2403

1.56

23.16

1.2

260.00

134.00

titre

0.67

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

583

2098

1.60

23.09

2.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2087

9424

1.28

23.04

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

921

3666

1.45

22.87

1.4

445.25

351.48

pmol/l

0.39

798

3185

(3010375) cycloSPORINE [Mass/volume] in Blood

395

1283

1.77

22.86

28.7

28.2

118.13

117.42

ug/l

0.07

331

1061

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

826

3220

1.48

22.82

3.1

3.3

5.68

7.77

nmol/l

0.55

797

3127

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

330

1015

1.87

22.73

2.7

2.9

28.88

28.56

umol/l

0.16

239

781

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5060

33530

0.86

22.68

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

993

4015

1.43

22.68

2.7

1139.53

604.54

u/ml

0.25

976

3967

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1120

4628

1.40

22.62

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1315

5585

1.36

22.46

3.4

3.3

565.83

891.29

u/ml

0.81

1205

5058

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1685

7431

1.31

22.27

1.9

14.71

13.56

iu/l

0.05

595

2772

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1002

4075

1.42

22.17

1.1

1.52

1.50

g/l

1.19

896

3703

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

862

3409

1.46

22.16

2.3

2.0

23.28

26.41

mg/l

0.84

225

921

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

353

1127

1.80

21.66

2.7

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1356

5830

1.34

21.41

1.5

111.67

111.48

u/ml

0.02

300

1340

(3051611) Lipemic interference index of Serum or Plasma

756

2940

1.48

21.18

3.7

3.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.33

21.11

1.2

1.0

—

mmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1733

7731

1.29

21.05

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

532

1917

1.60

21.02

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1745

7802

1.29

20.84

1.3

7.09

8.08

u/ml

0.29

252

1242

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

646

2441

1.52

20.77

1.7

2.2

17.88

18.42

nmol/l

0.80

591

2330

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

778

3056

1.47

20.75

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

426

1455

1.68

20.74

2.2

27.96

36.28

umol/l

0.48

141

(3020717) Zinc [Moles/volume] in Serum or Plasma

417

1416

1.69

20.74

1.7

1.5

22.36

25.70

umol/l

1.42

395

1352

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6562

33315

1.14

20.69

2.1

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1618

7173

1.30

20.61

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

1781

7999

1.29

20.55

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

532

1928

1.59

20.54

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

610

2282

1.54

20.53

2.1

73.92

72.44

1.62

577

2203

(3020876) Protein [Mass/time] in 24 hour Urine

784

3091

1.46

20.52

2.8

2.5

1.13

1.36

g/24h

1.55

391

1583

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

465

1631

1.64

20.48

1.3

1.2

28.31

23.80

u/l

0.87

393

1419

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

451

1570

1.65

20.45

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1056

4398

1.38

20.41

1.4

1.3

37.35

34.13

u/l

0.28

926

3829

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

6.01

20.38

1.6

308.65

269.61

nmol/l

0.13

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

476

1682

1.63

20.37

1.3

1.2

94.76

91.27

u/l

0.26

406

1491

(40768806) Pleura Pathology biopsy report

692

2666

1.49

20.32

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1234

5273

1.35

20.31

1.9

4.91

5.34

mmol/24h

3.02

1080

4717

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

619

2329

1.53

20.31

1.3

1.2

2.06

2.09

mmol/l

0.19

572

2163

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

331

1058

1.80

20.28

2.5

2.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1717

7693

1.29

20.19

1.3

6.60

5.84

u/ml

0.11

146

830

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

380

1267

1.73

20.19

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

7242

37071

1.14

20.14

2.2

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

380

1268

1.72

20.13

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

449

1569

1.65

20.08

1.3

1.2

270.02

334.64

u/l

0.77

410

1476

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

473

1676

1.62

20.03

2.7

2.8

39.91

39.12

0.33

241

932

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

457

1607

1.64

19.95

1.1

—

(3045424) Erythrocytes [Presence] in Urine

1171

4980

1.36

19.89

1.5

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

598

2244

1.53

19.87

1.1

293.19

421.87

mg/l

0.48

533

2015

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

560

2071

1.56

19.85

2.4

2.5

516.98

535.83

e6/l

0.30

452

1749

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

425

1469

1.66

19.82

1.6

1.4

—

(3021788) Differential panel - Synovial fluid

1228

5277

1.34

19.50

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

596

2252

1.52

19.21

2.1

14.89

15.14

0.24

574

2195

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

388

1322

1.69

19.11

1.5

1.6

17.55

5.21

nmol/l

0.45

327

1101

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

508

1854

1.58

19.09

1.5

25.20

24.81

u/ml

0.05

381

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

425

1485

1.65

19.04

1.6

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

613

2335

1.51

19.04

1.3

556.03

494.58

u/l

0.26

580

2210

(3000034) Microalbumin [Mass/volume] in Urine

663

2569

1.49

18.98

3.0

49.51

56.51

mg/l

0.24

470

1845

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

470

1690

1.60

18.80

1.6

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

410

1425

1.66

18.76

1.1

3.52

4.14

iu/ml

0.49

118

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.10

18.71

1.5

1.6

251.61

246.51

nmol/l

0.02

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

303

971

1.79

18.47

1.4

14.48

14.98

pmol/l

0.78

248

823

(3014271) Vancomycin [Susceptibility]

373

1270

1.69

18.44

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3054

14731

1.20

18.32

1.1

168.10

205.73

titre

0.43

396

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

648

2521

1.48

18.21

4.5

3.5

40.85

50.04

u/ml

0.58

639

2494

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2046

9485

1.25

18.15

1.6

14.23

4.90

iu/ml

0.45

441

1982

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

500

1843

1.56

18.04

1.2

1.3

14.76

14.03

u/l

0.23

459

1707

(3017704) Immunofixation for Urine

402

1408

1.64

17.89

1.8

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

447

1609

1.60

17.84

1.3

485.31

451.65

titre

0.05

115

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

719

2870

1.44

17.73

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

785

3185

1.42

17.72

1.1

11.53

72.68

au/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

189

523

2.08

17.64

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2477

11755

1.22

17.62

1.7

3.84

3.90

mg/l

0.11

1981

8452

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

535

2014

1.53

17.60

2.5

2.6

0.23

e9/l

0.07

451

1744

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1896

8748

1.25

17.56

1.1

3.94

5.72

u/ml

1.21

199

1229

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

192

536

2.06

17.52

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

434

1563

1.60

17.30

1.3

73.06

77.72

titre

0.10

136

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1785

8194

1.26

17.28

1.2

—

(3044927) Protein electrophoresis panel - Urine

658

2598

1.46

17.20

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

389

1366

1.64

17.16

36.2

36.5

7.12

7.45

ug/l

2.77

352

1247

(3012441) Differential panel - Pleural fluid

678

2694

1.45

17.15

1.4

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1410

6295

1.29

17.11

1.2

5.00

5.35

u/ml

0.08

503

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

360

1241

1.67

17.05

3.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

557

2133

1.50

16.94

2.0

1.8

3.73

3.76

mg/l

0.06

529

2036

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

426

1537

1.59

16.87

1.8

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

526

1992

1.52

16.86

1.3

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1117

4848

1.33

16.66

1.5

1.4

0.33

0.43

nmol/l

3.82

862

3795

(3047189) Immunofixation for 24 hour Urine

340

1165

1.68

16.49

2.1

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

527

2008

1.51

16.44

1.3

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

311

1041

1.72

16.42

1.3

1.5

72.30

72.74

0.20

294

992

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

306

1020

1.73

16.40

1.3

1.5

677.62

730.14

mu/l

0.13

289

971

(3010503) CD19 cells [#/volume] in Blood

474

1768

1.54

16.30

2.7

2.6

0.20

0.36

e9/l

1.08

457

1729

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

398

1426

1.61

16.24

1.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

456

1688

1.55

16.22

1.1

3.37

5.28

nmol/l

0.37

341

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

236

730

1.86

16.17

1.3

120.65

128.16

nmol/l

0.33

178

544

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

398

1428

1.60

16.16

1.9

—

(3022621) pH of Urine by Test strip

3883

19322

1.16

16.08

3.1

2.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1392

6269

1.28

15.82

1.2

4.73

15.37

u/ml

1.22

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

793

3292

1.39

15.76

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

656

2634

1.43

15.75

1.3

1.46

1.43

nmol/l

0.35

586

2386

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

320

1095

1.68

15.63

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

320

1096

1.68

15.58

2.0

2.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

619

2465

1.45

15.54

1.3

6.34

6.26

mmol/l

0.30

564

2285

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1899

8891

1.23

15.44

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

267

872

1.76

15.39

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

495

1892

1.51

15.26

3.1

3.3

136.14

129.27

nmol/l

0.15

484

1863

(40768441) Liver Pathology biopsy report

546

2132

1.47

15.17

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

321

1112

1.66

15.00

2.0

2.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

160

443

2.08

15.00

1.9

2.0

1.20

1.19

mmol/l

0.73

155

422

(3017509) Phencyclidine [Presence] in Urine

127

320

2.28

14.94

2.1

1.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

399

1469

1.56

14.60

1.3

58.26

63.06

0.44

175

(3045142) Bone marrow Pathology biopsy report

721

2997

1.38

14.27

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

467

1792

1.50

14.17

2.0

2.2

99.02

97.82

0.30

435

1674

(3000093) Morphology [Interpretation] in Blood Narrative

656

2696

1.40

13.90

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

249

824

1.74

13.79

2.1

1.8

7201.44

12736.28

e6/l

0.83

150

424

(3014051) Protein [Presence] in Urine by Test strip

1605

7478

1.24

13.71

2.6

2.4

—

(3004451) EKG impression Narrative

355

1298

1.57

13.43

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

273

935

1.68

13.39

2.2

1.9

2349.29

3696.12

e6/l

0.27

188

634

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

459

1778

1.48

13.35

1.7

1.5

6.51

7.05

u/l

0.35

358

1433

(40768446) Kidney Pathology biopsy report

335

1213

1.59

13.21

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

164

482

1.96

13.17

1.8

2.1

1.19

1.18

mmol/l

0.74

159

460

(3028717) Thiamine [Mass/volume] in Blood

110

276

2.29

13.13

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1296

5928

1.26

13.06

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

337

1226

1.58

13.04

2.7

2.4

9.58

9.87

mmol/l

0.74

327

1189

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

907

3964

1.32

13.01

1.7

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

442

1710

1.49

12.95

1.1

1.08

1.07

u/l

0.10

194

778

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

493

1958

1.45

12.67

1.7

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

445

1733

1.48

12.64

1.5

1.4

6.13

5.90

u/l

0.15

367

1469

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

546

2211

1.42

12.64

1.3

1.41

1.96

u/ml

0.74

335

1189

(3039162) Centromere protein B Ab [Units/volume] in Serum

867

3786

1.32

12.53

1.3

1.2

62.27

48.92

u/ml

0.68

243

(3037692) Legionella sp identified in Specimen by Organism specific culture

270

940

1.65

12.49

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

613

2540

1.39

12.45

1.2

1.1

38.42

43.69

mg/l

1.68

513

2128

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

311

1124

1.59

12.40

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

350

1302

1.55

12.34

1.5

—

(3025577) Chromium [Mass/volume] in Blood

403

1549

1.50

12.22

2.0

2.1

2.13

2.36

ug/l

0.47

339

1292

(40757373) Influenza virus identified in Isolate

170

520

1.88

12.20

1.7

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

121

327

2.13

12.17

3.4

3.3

41.69

41.71

umol/l

0.00

107

276

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

564

4452

0.72

12.16

1.4

1.3

2.68

3.56

ug/l

2.93

472

3949

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

349

1302

1.54

12.15

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

556

2276

1.41

12.13

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

592

2452

1.39

12.07

1.1

257.65

270.48

mg/l

0.69

522

2154

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

838

3663

1.32

12.05

1.5

1.6

57.43

57.30

0.03

536

2342

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

575

2371

1.40

12.04

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

225

754

1.71

12.00

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

160

483

1.90

11.95

2.6

2.5

47.27

49.69

mg/l

0.05

(3002079) Sodium [Moles/time] in 24 hour Urine

368

1397

1.51

11.85

1.2

155.08

161.14

mmol/24h

0.59

368

1397

(43055514) Macroprolactin [Presence] in Serum or Plasma

227

766

1.70

11.82

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

352

1328

1.52

11.68

3.1

3.3

—

(21494434) Karyotype in Bone marrow

561

2320

1.39

11.57

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

386

1491

1.49

11.47

8.4

5.7

972.37

3693.50

u/ml

0.59

120

278

(3002331) Protein [Mass/volume] in Peritoneal fluid

182

581

1.80

11.47

1.4

34.84

35.80

g/l

0.03

133

452

(4146454) Self-monitoring of blood glucose

698

2996

1.34

11.41

2.6

2.8

—

(3033799) Differential panel - Peritoneal fluid

235

810

1.67

11.35

2.2

1.8

—

(3028433) Virus identified in Specimen by Culture

265

945

1.61

11.22

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

241

2.26

11.14

2.1

2.0

1.26

1.33

umol/l

1.18

212

(3023420) DNA double strand Ab [Units/volume] in Serum

760

3315

1.32

11.14

1.6

1.5

24.42

34.96

iu/ml

1.77

153

(3026470) Cobalt [Mass/volume] in Blood

407

1602

1.46

11.03

1.9

2.0

3.13

3.67

ug/l

0.61

373

1463

(3001964) Herpes simplex virus Ag [Presence] in Specimen

245

863

1.63

10.91

1.6

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

312

1165

1.54

10.89

2.0

2.2

9.43

10.67

1.21

289

1082

(3022493) Free Hemoglobin [Mass/volume] in Plasma

327

1235

1.52

10.84

5.9

5.1

644.73

2815.89

mg/l

1.85

251

869

(3017817) Protein [Mass] in Urine collected for unspecified duration

612

2601

1.35

10.71

2.5

0.71

0.66

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

202

2.36

10.69

1.6

1.9

44.45

46.07

umol/l

0.20

202

(3035880) pH of Pleural fluid

362

1403

1.48

10.63

1.3

—

(40768793) Breast Pathology biopsy report

1340

6310

1.22

10.47

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

550

2309

1.37

10.42

1.1

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

305

1145

1.53

10.42

1.9

2.1

30.04

28.72

0.75

285

1087

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

490

2019

1.40

10.39

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

254

915

1.60

10.37

1.2

23.00

20.82

0.17

157

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

429

1728

1.43

10.34

1.0

274.42

346.44

ng/l

2.36

322

1215

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1292

6070

1.23

10.33

2.0

2.1

0.89

0.84

nmol/l

1.74

1061

5130

(3000060) B lymphocytes [#/volume] in Blood

241

858

1.61

10.32

1.9

2.2

746.06

715.47

e6/l

0.02

127

464

(3041918) Cholesterol [Moles/volume] in Pleural fluid

145

446

1.87

10.32

1.2

1.46

1.73

mmol/l

1.89

278

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

550

2314

1.37

10.29

1.1

1.2

—

(3013762) Body weight Measured

2.99

10.22

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

549

2312

1.37

10.21

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

553

2332

1.36

10.20

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

553

2333

1.36

10.17

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

353

1374

1.48

10.17

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1070

4936

1.25

10.14

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

553

2337

1.36

10.07

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

429

1743

1.42

9.88

1.0

791.98

731.32

ng/l

1.85

302

1188

(40762365) Oxygen content in Arterial blood by calculation

143

445

1.85

9.85

3.1

3.0

14.85

14.78

ml/dl

0.09

130

419

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

109

309

2.03

9.80

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

429

1746

1.41

9.79

1.0

43.11

41.48

ng/l

0.13

313

1209

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3175

16137

1.14

9.78

2.0

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

249

907

1.58

9.74

2.2

1.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

273

1017

1.54

9.69

1.3

1.1

0.65

0.45

g/l

0.25

(3026692) Albumin [Mass/volume] in Peritoneal fluid

193

660

1.68

9.68

1.5

1.4

13.03

13.46

g/l

0.24

133

512

(3008536) Aspergillus sp Ab [Presence] in Serum

166

544

1.75

9.68

1.9

2.2

—

(3006270) Folate [Moles/volume] in Blood

567

2427

1.34

9.54

1.2

378.37

368.00

nmol/l

0.55

481

2061

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9252

49676

1.08

9.53

1.7

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

206

720

1.64

9.53

1.4

1.3

16.68

16.95

umol/l

0.33

187

637

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6743

35746

1.09

9.45

1.6

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

236

858

1.58

9.33

1.0

1.1

—

(3016228) CD19 cells/100 cells in Blood

305

1175

1.49

9.30

2.3

2.0

7.35

8.60

1.13

293

1153

(3044007) Cell count panel - Peritoneal fluid

212

753

1.62

9.23

2.0

1.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

218

2.19

9.07

1.3

11.01

14.84

pmol/l

0.58

180

(3052592) Norovirus Ag [Presence] in Stool

162

538

1.73

9.06

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

412

1.84

9.05

1.1

—

(3036603) Volume of Urine

477

2005

1.37

9.05

1.5

1.6

2052.43

1967.50

0.65

462

1951

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

253

2.09

8.99

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

204

2.22

8.99

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

331

1306

1.46

8.98

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

277

2.03

8.93

2.2

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1066

4989

1.23

8.92

1.2

2.84

3.73

u/ml

1.15

329

1755

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

127

394

1.85

8.88

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

319

1255

1.46

8.79

9.1

9.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

224

817

1.58

8.77

1.5

1.6

10.02

8.82

ug/l

2.79

224

817

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

237

2.11

8.72

1.6

1.58

1.96

mg/l

0.32

146

(3033923) Metanephrine [Moles/time] in 24 hour Urine

165

558

1.70

8.68

1.1

0.72

3.23

umol/24h

0.52

292

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

262

993

1.52

8.67

1.8

1.6

42489.16

20425.35

u/ml

0.22

126

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3047

15575

1.13

8.60

3.4

3.1

47.30

49.05

u/ml

0.15

2935

15057

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.06

8.58

2.1

1.9

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

1.20

1.35

mg/l

0.10

131

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

1.80

2.28

mg/l

0.40

163

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

0.97

0.89

mg/l

0.06

145

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

3.01

2.26

mg/l

0.47

150

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

2.06

1.95

mg/l

0.05

139

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

1.95

2.32

mg/l

0.23

145

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

2.64

2.73

mg/l

0.04

154

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

1.78

1.89

mg/l

0.08

158

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

231

2.11

8.58

1.6

4.46

3.71

mg/l

0.38

145

(3006576) Bicarbonate [Moles/volume] in Blood

263

1001

1.51

8.54

5.0

6.5

24.85

25.14

mmol/l

0.47

244

907

(40761995) Spermatozoa Progressive [#/volume] in Semen

808

0.48

8.53

3.1

3.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

272

1043

1.50

8.53

1.8

2.5

1.03

1.12

ug/l

0.31

255

977

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

807

0.48

8.50

6.3

6.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

196

698

1.61

8.49

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

217

1897

0.66

8.44

1.8

—

(3042733) HLA Ab [Presence] in Serum

280

1084

1.48

8.39

5.1

5.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

972

4537

1.23

8.37

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

696

3126

1.28

8.35

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

295

1156

1.47

8.33

2.3

2.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

615

2719

1.30

8.33

1.3

1.4

122915.69

98045.86

e6/l

0.42

410

1897

(3016244) Insulin [Units/volume] in Serum or Plasma

453

1917

1.36

8.28

2.7

3.5

28.17

27.88

mu/l

0.05

421

1816

(3008116) Ketones [Moles/volume] in Urine by Test strip

166

571

1.67

8.23

1.6

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

584

2568

1.31

8.23

1.4

1.3

162.39

186.94

pmol/l

1.38

584

2568

(3012565) Volume of 24 hour Urine

368

1507

1.40

8.21

2.3

2.1

1943.65

1999.49

0.42

327

1350

(3000330) Specific gravity of Urine by Test strip

2803

14311

1.13

8.09

3.8

3.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1028

4852

1.22

7.98

1.3

1.2

3.16

4.01

u/ml

2.33

427

2182

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

285

1.93

7.71

1.4

72.50

70.54

0.23

236

(3027923) C peptide [Moles/volume] in Serum or Plasma

388

1623

1.37

7.67

1.5

1.6

1.24

1.23

nmol/l

0.11

295

1292

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

763

3504

1.25

7.66

1.2

1.1

1.42

1.96

iu/ml

0.41

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

363

1503

1.39

7.63

1.1

83.92

84.60

u/l

0.06

326

1362

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1023

4852

1.21

7.59

1.1

11.08

11.03

au/ml

0.01

319

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1458

7157

1.17

7.37

2.3

128.09

110.58

ug/min

0.61

847

4337

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

132

441

1.72

7.33

1.1

2.60

8.18

pmol/l

0.72

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

622

2804

1.28

7.32

4.2

4.8

106.43

112.41

u/ml

0.07

175

910

(3038177) Helicobacter pylori Ab [Presence] in Serum

1097

5259

1.20

7.30

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

410

1749

1.35

7.20

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1008

4802

1.21

7.17

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

161

571

1.62

7.17

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

455

1974

1.33

7.14

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

360

1507

1.37

7.13

1.1

27.07

23.72

u/l

0.47

321

1367

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

306

1.86

7.10

1.3

94.81

286.70

u/l

0.65

224

(3029396) Erythrocyte agglutination [Presence] in Blood

915

0.55

7.09

2.5

3.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

299

1218

1.41

6.96

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

619

2809

1.27

6.93

1.4

1.6

32.09

31.00

0.28

383

1785

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

495

2184

1.30

6.90

1.4

12.16

umol/l

0.00

464

2083

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

152

537

1.63

6.90

2.4

2.5

6.98

7.60

mmol/l

1.23

101

312

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

311

1.83

6.78

2.2

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

177

652

1.56

6.77

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

206

785

1.51

6.77

1.3

3.72

3.49

mmol/l

0.36

188

725

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

153

2.21

6.76

1.1

1.05

1.22

u/field

0.96

103

(3047007) Chlamydophila sp Ab [Presence] in Serum

958

4579

1.20

6.63

1.3

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

144

2.23

6.56

1.5

1.8

0.75

0.68

umol/l

0.40

115

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

155

558

1.60

6.55

4.7

6.2

65.62

71.75

1.85

123

440

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

254

1017

1.43

6.53

1.2

112.39

111.08

0.30

227

908

(3003694) ABO and Rh group [Type] in Blood

14907

89031

0.95

6.53

1.4

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

974

4670

1.20

6.52

1.1

118.71

118.15

0.20

872

4254

(3024471) HLA-A [Type]

269

1089

1.42

6.52

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

213

1770

0.69

6.50

1.3

1.4

30.69

30.80

nmol/l

0.02

183

1618

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

118

397

1.71

6.46

3.8

2.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

191

724

1.52

6.46

1.4

1.3

38.71

38.93

0.02

135

482

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

280

1144

1.41

6.45

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

792

3727

1.22

6.44

1.3

—

(3002619) Bacteria identified in Specimen by Culture

159

579

1.58

6.42

1.3

1.2

—

(3024932) HLA-DR beta [Type]

263

1064

1.42

6.41

1.1

—

(4212803) Bone marrow aspirate examination

219

1.97

6.39

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

233

925

1.45

6.29

3.3

3.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

249

1001

1.43

6.29

1.1

91.10

91.82

0.08

125

472

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

363

1556

1.34

6.25

1.4

1.3

4.03

4.83

umol/l

4.05

333

1428

(3019420) Tryptase [Mass/volume] in Serum or Plasma

378

1633

1.33

6.18

1.5

8.69

7.92

ug/l

0.25

345

1478

(3048879) Bone marrow aspiration report

200

774

1.48

6.15

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

468

2085

1.29

6.13

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

319

1346

1.36

6.09

2.1

2.2

115.18

101.66

ug/min

0.14

307

(3043410) Blood group antigens tested for on Red Blood Cells

202

786

1.48

6.06

1.7

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1604

8057

1.15

6.05

1.8

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

134

476

1.62

6.02

1.3

1.4

108.51

276.11

ng/l

0.45

310

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

589

2707

1.25

5.99

1.3

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

192

743

1.48

5.93

1.7

2.0

39.84

38.88

u/l

0.03

173

669

(3035320) C reactive protein [Mass/volume] in Body fluid

478

2147

1.28

5.90

3.0

2.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

118

408

1.66

5.89

2.1

2.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

167

629

1.53

5.86

1.5

1.6

0.36

0.41

ug/l

0.93

111

406

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

126

444

1.63

5.85

1.4

1.3

0.20

0.27

nmol/l

0.99

306

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

267

1102

1.39

5.85

1.2

0.32

0.30

g/l

2.06

206

874

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

293

1.78

5.83

2.7

3.1

1.14

1.35

mg/l

0.48

201

(44813793) Dust mix specific IgE antibody measurement

485

2186

1.28

5.83

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

903

4350

1.19

5.80

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

163

613

1.53

5.77

2.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

257

1.83

5.73

1.1

23.99

19.42

u/l

0.95

161

(3024869) Neuronal Ab [Presence] in Serum

139

505

1.58

5.72

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

125

443

1.62

5.69

4.9

4.6

55.76

44.07

ug/min

1.02

102

347

(3032352) Blasts [#/volume] in Cerebral spinal fluid

296

1.77

5.65

1.7

2.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

196

770

1.46

5.64

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

557

0.49

5.64

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

253

1042

1.39

5.63

1.2

1.1

107.46

108.36

0.12

228

947

(3034274) Bile acid [Moles/volume] in Serum --fasting

598

4216

0.81

5.63

1.9

2.1

7.19

7.33

umol/l

0.06

437

3036

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

728

3450

1.21

5.59

1.1

98.86

95.67

2.37

671

3245

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

114

398

1.64

5.52

1.4

1.5

112639.03

262431.59

nmol/l

0.67

330

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

185

722

1.47

5.51

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

196

774

1.45

5.50

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

223

905

1.42

5.42

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

313

1.72

5.41

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

252

1045

1.39

5.41

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

193

763

1.45

5.40

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

249

1032

1.39

5.37

1.1

88.70

91.09

0.47

121

486

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

774

1.45

5.35

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

151

569

1.52

5.33

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

330

1432

1.32

5.31

1.4

1.5

4.45

3.80

0.23

333

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

176

686

1.47

5.30

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3897

20700

1.09

5.27

2.1

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

320

1.70

5.27

1.2

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

719

3427

1.21

5.24

2.7

2.3

105.33

105.76

mmol/l

1.42

713

3398

(3041354) Potassium [Moles/volume] in Venous blood

719

3429

1.21

5.21

2.7

2.3

4.06

4.05

mmol/l

0.21

713

3400

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

534

1.53

5.09

4.7

5.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

106

372

1.64

5.07

1.3

1.08

1.29

mmol/l

0.13

237

(3009542) Hematocrit [Volume Fraction] of Blood

61425

350458

1.07

5.05

28.3

18.5

40.07

40.66

8.21

57577

330062

(3028679) Herpes simplex virus Ab [Presence] in Serum

377

1679

1.29

5.05

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

138

2.08

5.03

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

204

1.86

4.88

3.6

2.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

281

1213

1.33

4.74

1.1

728.24

423.01

ng/l

0.40

280

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

121

447

1.55

4.72

1.0

79.83

82.07

ug/l

0.23

367

(3024263) Appearance of Synovial fluid

343

1524

1.29

4.71

1.3

1.4

—

(3016750) Collection duration of Urine

385

1739

1.27

4.65

2.2

507.76

497.86

min

1.16

282

1300

(40765089) Chromosome analysis panel - Blood by G-banded

117

1016

0.66

4.64

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

164

1.93

4.54

4.9

5.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

157

621

1.45

4.47

1.3

1.4

26.69

21.65

1.18

129

514

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

190

1.84

4.44

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

275

1.69

4.44

1.2

1.3

5.42

6.39

mmol/l

0.90

150

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

125

473

1.52

4.42

1.3

—

(3003129) Base excess in Capillary blood by calculation

171

691

1.42

4.35

1.8

1.6

0.76

0.40

mmol/l

0.51

162

648

(3002621) Streptococcal DNAse B [Units/volume] in Serum

260

1.70

4.31

1.0

1.1

—

(3007461) Platelets [#/volume] in Blood

61453

350805

1.06

4.30

28.2

18.5

253.70

252.20

e9/l

6.22

60197

341888

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1944

10109

1.11

4.24

1.3

211.39

221.40

miu/ml

0.52

750

4745

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

37245

210519

1.03

4.24

3.2

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

386

1.56

4.23

1.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

924

6103

0.87

4.20

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

117

2.06

4.19

11.7

8.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

110

411

1.54

4.14

1.1

1.3

34.97

43.63

mg/l

1.20

351

(3010370) Gastrin [Moles/volume] in Serum or Plasma

120

458

1.50

4.11

1.9

1.7

54.79

46.96

pmol/l

0.37

102

382

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

335

1.59

4.10

2.0

2.6

1.18

1.26

mmol/l

0.11

234

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

426

1.52

4.09

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

431

2006

1.23

4.08

1.1

7.93

8.56

iu/ml

0.18

111

511

(3001556) Androgen free Index in Serum or Plasma

297

1.62

3.99

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

181

1.81

3.95

1.5

1.3

15.84

17.34

pmol/l

0.27

154

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

194

1.78

3.93

7.7

4.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

274

1214

1.30

3.93

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

246

1.68

3.90

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

346

1580

1.26

3.90

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

209

1.73

3.80

3.7

2.7

86.36

71.69

pmol/l

0.09

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

222

1.71

3.80

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

394

1836

1.23

3.73

5.9

6.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.50

3.71

1.8

2.6

1.49

2.43

mu/l

0.94

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

322

1468

1.26

3.71

1.7

1.9

146.11

141.86

0.44

298

1388

(3038026) Centromere Ab [Units/volume] in Serum

507

2425

1.20

3.71

1.2

57.21

53.38

u/ml

0.07

110

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

326

1.57

3.70

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

689

3385

1.17

3.70

2.8

2.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

170

709

1.38

3.68

1.4

21.79

22.79

0.18

151

646

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

163

676

1.38

3.66

1.2

407.23

298.02

pmol/l

0.53

115

510

(3001686) Cold agglutinin [Titer] in Serum or Plasma

126

499

1.45

3.65

1.2

1.4

114.94

171.06

titre

0.35

(3001893) Eosinophils/100 leukocytes in Pleural fluid

186

789

1.35

3.63

1.4

3.66

2.60

0.81

158

662

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

118

462

1.47

3.62

1.2

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

172

721

1.37

3.62

1.2

1.3

262.28

268.41

ug/l

0.01

384

(40758292) HTLV I+II Ab panel - Serum

123

486

1.45

3.61

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

320

1.56

3.57

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

176

743

1.36

3.56

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

474

2265

1.20

3.52

1.9

1.7

7.22

6.71

mmol/l

2.59

362

1640

(3014148) Varicella zoster virus Ab [Titer] in Serum

829

4147

1.15

3.52

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

166

696

1.37

3.51

1.1

6.92

6.87

mg/g

0.03

156

662

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

136

551

1.42

3.50

2.2

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

259

1.62

3.48

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

669

3300

1.17

3.44

2.4

2.3

—

(3035941) MCH [Entitic mass]

61462

351093

1.05

3.43

28.1

18.3

30.44

30.25

124.45

60707

346478

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

492

2368

1.19

3.40

1.2

73.92

68.49

u/ml

0.14

104

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

134

545

1.41

3.39

1.4

1.6

—

(3024731) MCV [Entitic volume]

61467

351138

1.05

3.37

28.1

18.4

91.41

90.72

255.64

60706

346513

(3026361) Erythrocytes [#/volume] in Blood

61470

351168

1.05

3.33

28.2

18.4

4.44

4.53

e12/l

307.65

60071

341278

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

492

2374

1.19

3.32

1.2

48.17

45.93

u/ml

0.07

172

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

473

2276

1.19

3.29

1.2

3.21

8.91

u/ml

1.81

152

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

319

1476

1.24

3.28

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

112

444

1.45

3.27

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

167

1.75

3.27

1.1

48.33

88.53

u/l

0.52

132

(3008037) Lactate [Moles/volume] in Venous blood

1203

6195

1.12

3.26

3.9

3.0

1.59

1.58

mmol/l

0.12

1174

6071

(3010813) Leukocytes [#/volume] in Blood

61470

351201

1.05

3.21

28.2

18.4

6.88

6.69

e9/l

63.74

60076

341260

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

683

3398

1.16

3.18

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

348

1632

1.22

3.17

1.8

1.7

2.82

2.34

u/field

0.57

267

1164

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

186

1.70

3.17

1.4

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

200

1.66

3.12

1.2

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

115

1.90

3.12

1.1

1.3

0.06

0.07

g/l

1.35

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

100

392

1.46

3.11

2.2

2.7

57.49

75.70

pmol/l

0.92

347

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

168

721

1.34

3.11

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

168

721

1.34

3.11

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

168

721

1.34

3.11

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

168

721

1.34

3.11

1.1

—

(3008898) HLA-B27 [Presence]

2109

11188

1.08

3.10

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

286

1.55

3.08

1.2

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

238

1074

1.27

3.06

1.7

2.0

176.75

164.15

0.84

228

1011

(3000963) Hemoglobin [Mass/volume] in Blood

61475

351281

1.05

3.04

28.4

18.5

134.33

136.39

g/l

213.99

60735

346670

(3032743) Legionella sp IgG Ab [Presence] in Serum

193

1.67

3.03

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

142

598

1.36

2.98

1.2

1.3

65.60

68.36

mu/l

0.07

100

457

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

276

1272

1.25

2.98

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

153

653

1.35

2.96

1.3

1.2

89.34

89.77

0.03

184

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.17

2.93

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

222

1.60

2.91

1.2

17.59

14.64

nmol/l

0.95

(3036670) Protein [Mass/volume] in Synovial fluid

189

835

1.30

2.89

1.3

1.2

39.03

40.26

g/l

0.55

467

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

152

651

1.34

2.88

1.2

83.76

76.48

0.67

176

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.62

2.87

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1229

6386

1.11

2.87

4.2

3.1

26.09

26.77

mg/l

0.25

751

4024

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

371

1.45

2.86

1.7

1.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

158

682

1.33

2.85

1.2

1.3

109.86

107.15

0.45

152

644

(1761482) Bacteria [#/volume] in Urine by Culture

1391

7276

1.10

2.84

4.6

3.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

115

1.85

2.84

1.1

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

165

1234

0.77

2.82

1.1

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

316

1.49

2.81

2.3

2.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.93

2.80

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

699

1.32

2.80

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

189

1.64

2.78

1.2

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

309

1454

1.22

2.78

1.1

5.69

9.06

u/ml

1.25

254

(3019897) Erythrocyte distribution width [Ratio] by Automated count

739

4801

0.88

2.77

3.3

2.4

13.19

13.16

0.44

730

4736

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

374

1.44

2.76

1.3

—

(40768795) Lymph node Pathology biopsy report

578

2875

1.16

2.76

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

192

1403

0.78

2.74

1.1

1.2

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.07

2.73

1.3

1.1

502.70

318.84

pmol/l

0.31

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

337

1.47

2.73

1.5

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.04

2.73

4.3

6.7

1.24

1.43

mg/l

0.13

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

478

2348

1.17

2.69

2.0

1.9

2.00

2.31

u/field

0.59

227

1022

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

165

1.67

2.66

1.0

1.1

1.35

3.33

u/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10640

59276

1.04

2.66

1.6

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

305

1442

1.21

2.64

1.1

1598.02

1509.26

miu/ml

0.65

305

1442

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

341

1.45

2.59

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.87

2.59

1.0

1.1

132.71

234.13

pmol/l

1.57

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

234

1.55

2.58

2.5

2.2

62.18

58.41

0.33

140

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.96

2.57

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.25

2.56

1.3

51.92

44.86

e6/l

0.09

(40765096) Chromosome analysis panel by Banding

177

790

1.29

2.55

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

125

531

1.35

2.55

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

2.55

0.0

1.1

—

70.01

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

713

3621

1.13

2.54

2.4

2.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1929

11898

0.93

2.53

1.8

1.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

125

954

0.75

2.52

1.6

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

103

425

1.39

2.51

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

102

421

1.39

2.48

1.0

0.33

u/ml

0.00

263

(3013166) Neutrophils/100 leukocytes in Synovial fluid

198

900

1.26

2.48

1.3

1.4

54.51

54.10

0.05

163

784

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

207

946

1.26

2.48

1.4

61.77

61.45

0.05

172

773

(3024316) Viscosity of Plasma

138

1.71

2.47

1.6

1.8

1.59

1.69

mpas

0.27

(3038515) Glucose [Moles/volume] in Venous blood

1120

5845

1.10

2.46

4.0

3.1

7.39

7.60

mmol/l

1.68

1094

5743

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

228

1.54

2.45

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.16

2.44

1.5

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

120

0.38

2.40

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

211

1.55

2.39

1.3

1.2

104.66

106.57

ug/l

0.04

136

(40762814) Titanium [Mass/volume] in Blood

108

454

1.37

2.38

2.1

2.3

3.49

3.80

ug/l

0.33

158

(3025130) Human papilloma virus identified in Specimen

873

4510

1.11

2.35

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

263

1.48

2.35

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

217

0.50

2.35

1.0

0.39

1.11

u/ml

0.71

145

(3049233) Organic acids panel - Urine

2.32

2.34

1.4

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

325

1.43

2.33

1.3

23.05

25.43

0.28

246

(3030313) Adrenal Ab [Titer] in Serum

283

1.46

2.31

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

251

1.49

2.27

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

237

1112

1.22

2.27

2.0

1.9

8.63

9.30

mg/l

1.07

184

897

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

194

891

1.25

2.26

1.7

1.6

119.01

134.75

au/ml

0.17

110

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

225

1051

1.23

2.25

1.2

1.1

—

(3006598) pH of Arterial cord blood

174

0.46

2.22

1.0

—

(3004775) Volume in Urine collected for unspecified duration

475

2373

1.15

2.22

2.3

730.37

670.35

1.96

339

1617

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

152

1.62

2.20

3.6

3.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

130

1.68

2.20

1.3

1.4

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

113

1.73

2.17

1.1

1.4

1.28

1.00

u/field

0.89

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

150

672

1.28

2.16

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9108

50797

1.03

2.15

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

250

1.47

2.14

1.2

1.3

1.12

1.52

ml/s/173m2

0.52

164

(3005011) Chlamydia sp Ab [Titer] in Serum

409

1.36

2.13

1.7

1.6

—

(3028468) Fragments [Presence] in Blood by Light microscopy

3.23

2.13

2.7

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

293

1.43

2.13

1.1

1.73

2.98

umol/24h

0.50

293

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

395

1.37

2.11

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

218

1.50

2.11

1.1

9.21

9.97

u/l

0.16

218

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

951

4968

1.10

2.10

1.1

10796.81

915.83

iu/ml

0.44

205

1102

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.97

2.10

1.0

0.29

0.93

u/ml

0.76

(3034426) Prothrombin time (PT)

229

1083

1.21

2.07

1.2

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

5.74

2.03

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.94

2.02

2.7

2.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

179

1.54

2.01

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

331

1.39

1.99

1.7

1.6

114.27

111.08

ug/l

0.08

273

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.82

1.99

1.2

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

719

4573

0.90

1.98

1.2

1.3

7.30

7.12

mmol/l

0.76

643

4042

(3007147) Virus identified in Stool by Electron microscopy

3.28

1.97

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.75

1.97

1.1

—

(3041184) Isoniazid [Presence] in Urine

2.41

1.95

2.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

163

1.55

1.91

1.5

1.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

191

1.50

1.89

1.6

1.8

0.96

0.63

0.38

147

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.14

1.87

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

606

3873

0.90

1.85

1.0

0.50

0.44

u/ml

0.13

164

1014

(3020650) Glucose [Presence] in Urine

177

828

1.23

1.82

1.5

1.4

—

(3013931) Oligosaccharides [Presence] in Urine

4.78

1.82

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

426

1.32

1.82

2.4

—

(3012898) Urea [Moles/volume] in Urine

313

1.38

1.81

1.4

1.6

156.53

173.52

mmol/l

0.63

278

(3035082) Kappa light chains [Mass/volume] in Urine

1.86

1.80

1.1

0.51

0.04

g/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

184

1.50

1.80

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

417

1.32

1.79

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

135

614

1.26

1.79

1.2

30.75

48.07

mg/l

0.21

107

441

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1312

7008

1.08

1.78

1.4

135.01

124.76

pmol/l

0.29

1277

6846

(1617658) Protocol used for examination of sentinel lymph nodes

420

2121

1.14

1.76

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

364

1.34

1.75

2.4

2.5

0.58

0.57

u/field

0.02

364

(3051339) Copper [Moles/volume] in Blood

158

1.53

1.73

1.1

1.3

16.88

16.69

umol/l

0.09

137

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.69

1.72

1.0

1.1

1960.40

4284.01

ng/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

209

1002

1.20

1.70

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.43

1.69

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

337

1.35

1.68

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

114

1.61

1.66

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

428

1.30

1.65

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

431

2194

1.13

1.62

2.0

1.7

—

(3000285) Sodium [Moles/volume] in Blood

340

1.33

1.61

1.1

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

345

1.33

1.60

2.0

1.6

1.72

1.66

mg/l

0.15

290

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.80

1.59

1.1

1.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

262

1.38

1.59

1.0

1.1

2.88

5.38

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

887

4693

1.09

1.57

1.1

3.11

2.95

u/ml

0.10

360

2385

(3022689) Creatine [Moles/volume] in Urine

176

838

1.21

1.57

1.5

—

(4281824) Cell count and differential, peritoneal fluid

597

3104

1.10

1.55

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

150

704

1.22

1.55

1.1

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

130

1.55

1.2

1.12

0.57

umol/24h

0.44

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.95

1.53

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

429

1.28

1.51

1.1

—

(3001729) Color of Synovial fluid

226

1.40

1.50

1.5

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

185

890

1.19

1.50

2.4

1.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.82

1.50

1.2

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

150

1.49

1.5

1.7

209.79

190.89

ng/l

0.55

128

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

169

1.46

1.48

1.0

0.73

0.26

u/ml

0.47

154

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

502

1.26

1.48

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

146

1.49

1.46

1.2

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

305

1531

1.14

1.46

1.2

1.1

9.63

14.25

u/ml

0.28

155

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.68

1.46

1.0

1.1

24.71

32.00

umol/l

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.77

1.45

1.1

0.01

0.06

g/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

893

5527

0.93

1.44

1.1

1.24

1.80

u/ml

1.88

436

2664

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

191

1.41

1.38

1.3

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.68

1.37

9.5

8.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

227

1123

1.16

1.35

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

288

1451

1.14

1.33

1.1

96.01

97.93

0.52

228

1170

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

112

1.54

1.33

1.2

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

100

458

1.25

1.33

2.8

3084.52

1490.46

u/l

0.84

410

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

183

1.41

1.33

2.0

2.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

183

1.41

1.33

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

393

2019

1.12

1.33

1.2

1.1

1.08

1.07

ratio

0.39

145

711

(3027874) Urate [Moles/volume] in Urine

1.59

1.32

1.1

1.45

8.39

mmol/l

0.53

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

189

1.40

1.29

2.4

2.3

17.36

15.11

0.16

(3013945) Hepatitis B virus e Ab [Presence] in Serum

189

1.40

1.29

1.2

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

414

1.26

1.29

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

404

1.26

1.29

1.5

1.4

9.65

12.03

0.41

208

(3032641) Amino acids panel - Urine

2.10

1.28

1.5

1.3

—

(3018133) Calcium [Moles/volume] in Urine

102

471

1.24

1.28

2.1

1.9

2.48

2.69

mmol/l

0.54

422

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

275

1790

0.88

1.26

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

252

1649

0.88

1.25

1.3

—

(3014891) Appearance of Pleural fluid

360

1.28

1.25

1.3

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.65

1.24

9.9

7.9

43.92

43.90

0.00

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.61

1.24

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

119

561

1.22

1.24

2.5

1.7

6.05

2.92

ug/l

0.34

343

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

325

1.29

1.24

1.1

—

(3043614) Bacteria identified in Aspirate by Culture

2.87

1.23

1.2

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

1.21

0.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

148

1.44

1.21

1.2

—

(3013862) HLA-DP [Type]

115

1.50

1.21

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

111

1.50

1.18

1.2

1.1

2.00

1.00

u/field

0.44

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.51

1.16

1.0

1.3

17.27

36.74

nmol/24h

—

(46235168) Fasting glucose [Moles/volume] in Blood

400

0.76

1.16

2.1

1.8

7.48

7.35

mmol/l

0.09

140

(3036048) Francisella tularensis Ab [Titer] in Serum

145

704

1.18

1.13

1.3

1.2

509.09

507.88

titre

0.00

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

269

1.30

1.13

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

151

736

1.18

1.13

8.3

8.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.73

1.13

1.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.36

1.12

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

320

2046

0.90

1.12

1.0

1.1

2.21

2.75

u/ml

0.18

505

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.97

1.11

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

113

1.47

1.10

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

727

4475

0.93

1.09

1.1

3.87

4.67

u/ml

0.58

299

1826

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

115

550

1.20

1.08

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.59

1.06

1.3

1.7

180.40

110.37

ug/l

—

(3051101) Glucose [Moles/volume] in Cord blood

522

0.80

1.06

5.2

5.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

133

646

1.18

1.05

8.4

8.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.99

1.04

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

287

1835

0.90

1.03

1.0

0.54

0.99

u/ml

0.52

432

(40760410) HLA-B [Type] by High resolution

115

1.45

1.02

1.0

—

(40760409) HLA-A [Type] by High resolution

115

1.45

1.02

1.0

—

(46236302) HLA-C [Type] by High resolution typing

115

1.45

1.02

1.0

—

(36304079) Mucus [Presence] in Urine sediment

2.39

1.02

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

154

1.38

1.01

11.4

9.6

198.00

314.90

e6/l

0.38

112

(37019676) Renin [Units/volume] in Plasma --supine

1.61

1.01

1.1

27.14

63.82

mu/l

0.77

(3019768) Coxiella burnetii Ab [Presence] in Serum

174

1.35

1.00

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

409

2146

1.09

0.99

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.46

0.98

1.2

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.46

0.98

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

425

1.22

0.98

1.4

1.3

59.51

50.49

0.90

201

(3022475) Manganese [Moles/volume] in Blood

190

1.33

0.97

1.1

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1102

5998

1.06

0.97

1.7

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

473

1.20

0.96

5.5

7.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

146

1.38

0.96

1.1

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

171

0.67

0.96

1.0

1.1

0.67

11.78

u/ml

0.48

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

364

1.23

0.96

2.2

1.2

9.53

63.87

u/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

385

1.22

0.95

1.2

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

219

1117

1.13

0.93

1.7

1.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

172

1.33

0.92

1.2

1.3

558.67

1120.26

u/l

0.44

151

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

675

0.84

0.92

3.1

2.6

96.78

106.47

ng/l

0.25

340

(3027231) Wheat IgE Ab [Units/volume] in Serum

656

0.84

0.92

1.1

0.77

1.26

u/ml

0.56

555

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

289

1.25

0.91

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.67

0.90

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

605

3716

0.93

0.90

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

124

1.39

0.88

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

139

1.36

0.87

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

778

4731

0.94

0.86

1.1

3.33

4.17

u/ml

0.74

349

2198

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.58

0.86

1.3

1.2

6.80

5.52

mg/l

0.12

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

115

1.40

0.86

2.1

1.3

—

(36303858) Crystals [Presence] in Urine

1.72

0.85

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.55

0.84

1.2

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

101

1.42

0.84

1.0

1.1

5.89

5.20

mmol/l

0.32

(3007700) Barley IgE Ab [Units/volume] in Serum

152

0.68

0.83

1.0

1.1

0.10

9.98

u/ml

0.52

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

106

1.41

0.83

1.0

1.2

230.10

275.64

nmol/l

0.82

106

(3003888) Timothy IgE Ab [Units/volume] in Serum

982

5922

0.95

0.82

1.1

4.42

4.98

u/ml

0.50

478

3022

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

176

1.30

0.81

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

935

5636

0.95

0.78

1.1

0.96

1.08

u/ml

0.24

378

2350

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.57

0.78

1.3

1.4

0.71

0.61

u/field

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.57

0.78

2.0

2.2

—

(40768800) Prostate Pathology biopsy report

1047

5735

1.05

0.78

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

274

1433

1.10

0.77

1.9

2.2

18.92

214.18

ug/l

1.86

258

1370

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.21

0.76

1.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.21

0.76

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.21

0.76

1.0

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

168

1.30

0.76

1.1

1.4

1.30

1.64

0.21

105

(3009992) Blasts/100 cells in Bone marrow

1.91

0.76

1.7

1.8

16.86

18.38

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.83

0.73

1.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

284

0.79

0.73

1.5

1.6

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

314

1.21

0.73

2.5

2.4

23.05

21.82

mg/l

0.28

297

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

180

0.73

0.72

1.0

1.1

6.02

6.92

u/ml

0.14

128

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.59

0.72

3.2

4.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

226

1.24

0.72

1.3

1.2

2.11

26.13

—

(3016031) Almond IgE Ab [Units/volume] in Serum

206

0.75

0.72

1.1

1.0

0.14

0.64

u/ml

2.58

115

(3020123) Porphyrins [Interpretation] in Serum or Plasma

180

1.28

0.71

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.66

0.71

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3088

18163

0.97

0.70

1.8

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

120

1.34

0.70

1.3

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

161

1.28

0.68

1.4

1.8

259.42

156.47

ug/g

1.78

135

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.67

0.68

1.1

1.3

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.67

0.68

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

151

1.29

0.68

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

184

0.75

0.67

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.46

0.67

1.1

1.0

0.05

0.21

u/ml

0.53

(3045683) HLA typing for celiac disease panel - Blood or Tissue

369

1972

1.07

0.66

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

203

0.76

0.66

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.52

0.65

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.52

0.65

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1095

6540

0.96

0.65

1.1

1.74

1.89

u/ml

0.23

537

3246

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

187

971

1.11

0.65

1.1

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.79

0.65

1.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.79

0.65

1.2

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

142

1.29

0.65

1.6

1.5

0.22

0.11

u/l

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.70

0.64

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

178

1.26

0.64

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

391

0.84

0.63

12.9

5.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

230

1440

0.92

0.63

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.37

0.61

2.6

3.4

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

0.09

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

211

1.22

0.60

2.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

334

2053

0.93

0.59

1.0

1.1

2.25

1.72

u/ml

0.11

117

651

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.35

0.58

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

178

929

1.10

0.58

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

307

1.18

0.57

2.6

2.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

197

1.22

0.57

1.5

9.63

14.19

0.79

135

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.43

0.56

1.3

1.1

1.93

2.67

0.94

(4034850) Laboratory test

1710

10094

0.97

0.55

12.4

8.9

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.48

0.54

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

209

0.80

0.54

1.1

1.3

—

(3022670) pH of Venous cord blood

0.60

0.54

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

283

1741

0.93

0.54

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

278

1.18

0.53

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.33

0.52

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

107

1.29

0.50

1.8

3.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

138

1.25

0.49

1.0

0.11

0.13

u/ml

0.09

(3027035) Albumin [Mass/time] in 24 hour Urine

291

1.16

0.49

1.4

1.3

234.93

362.26

mg/24h

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.39

0.49

1.5

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.60

0.47

1.0

1.1

1016.00

2210.63

titre

—

(3011544) Albumin [Mass/volume] in Pleural fluid

255

1.17

0.47

1.1

17.87

17.17

g/l

0.25

229

(3013466) aPTT in Blood by Coagulation assay

197

1.19

0.46

1.2

1.1

35.72

36.83

0.49

167

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

118

613

1.10

0.46

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

118

613

1.10

0.46

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

336

1.14

0.46

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.41

0.46

1.0

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.39

0.46

1.0

489.00

335.36

umol/l

—

(3044336) Cobalt [Moles/volume] in Urine

0.70

0.45

2.0

2.5

8.19

28.12

nmol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

197

0.82

0.44

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

214

1.18

0.44

1.0

—

(3003338) MCHC [Mass/volume]

47246

271820

0.99

0.44

24.7

15.9

332.41

332.77

g/l

13.45

46911

269714

(3008607) Semen analysis panel

221

0.83

0.43

1.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.2

—

1.97

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

1.59

0.43

1.0

1.1

20.40

14.61

umol/l

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

126

1.23

0.41

1.0

0.05

0.09

u/ml

0.29

(3029612) Listeria sp Ab [Titer] in Serum

0.66

0.41

1.1

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

523

2881

1.04

0.40

1.3

9.23

8.36

mmol/l

3.77

492

2773

(3019174) dRVVT (LA screen)

292

1.14

0.40

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1956

11000

1.02

0.39

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.38

0.39

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

266

1443

1.06

0.38

3.1

3.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

213

1.16

0.37

3.9

4.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

223

0.85

0.37

1.0

0.20

0.74

u/ml

0.60

130

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

102

1.24

0.36

1.9

2.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

116

613

1.09

0.35

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.38

0.35

1.0

4.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.38

0.35

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

156

957

0.94

0.33

1.0

9.46

9.78

u/ml

0.06

541

(3002523) Influenza virus A Ag [Presence] in Specimen

960

5369

1.03

0.33

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

148

909

0.93

0.33

1.1

1.18

6.59

u/ml

0.81

503

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

146

1.18

0.33

1.4

1.3

1.92

1.63

mg/l

0.46

122

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

1.21

0.32

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

959

5372

1.02

0.30

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

220

1199

1.05

0.30

3.0

3.2

8.81

7.79

mg/l

0.94

173

956

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

229

1.13

0.29

1.4

1.5

38.44

37.55

0.05

145

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

100

1.21

0.29

1.0

0.17

0.21

u/ml

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.31

0.29

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

302

0.89

0.29

1.0

1.1

0.39

2.31

u/ml

2.09

222

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.24

0.27

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2211

12507

1.02

0.27

2.3

2.2

4922.69

5585.58

u/l

0.42

702

5060

(3044009) aPTT.lupus sensitive (LA screen)

302

1.10

0.26

1.3

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.26

0.26

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.26

0.26

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.26

0.26

1.9

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.26

0.26

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.26

0.26

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.26

0.26

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.29

0.25

2.2

5.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

132

714

1.06

0.25

1.3

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

1.37

0.24

1.0

1.1

85.00

88.06

umol/l

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

201

1104

1.05

0.23

2.4

2.7

112.36

156.36

au/ml

0.83

146

(3020399) Glucose [Mass/volume] in Urine

0.00

0.21

0.0

1.6

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.9

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

193

0.89

0.20

3.6

3.0

19.56

13.74

0.74

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

168

1005

0.96

0.19

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

299

0.92

0.19

1.0

0.54

1.65

u/ml

0.43

163

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.22

0.18

2.3

2.5

—

(3034614) HLA Ag [Interpretation]

1.18

0.18

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.21

0.17

1.4

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.15

0.16

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

112

1.13

0.16

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

408

1.06

0.14

1.0

—

(3003577) Lead [Moles/volume] in Blood

259

0.93

0.14

1.3

1.5

0.16

0.23

umol/l

0.68

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

163

1.09

0.14

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

152

1.09

0.14

1.7

2.3

2.76

11.18

nmol/l

1.57

144

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.85

0.13

3.6

5.7

0.27

0.25

mmol/l

0.10

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

449

1.05

0.13

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1866

10622

1.01

0.12

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

142

1.09

0.12

19.6

14.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.88

0.12

1.1

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

519

0.96

0.11

1.1

1.00

4.07

u/ml

1.55

368

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

239

1.06

0.10

1.0

1.1

6.91

19.45

iu/ml

2.02

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.15

0.09

1.2

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

295

0.95

0.09

1.3

1.2

22.58

20.79

mmol/l

1.59

235

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

289

0.95

0.09

1.0

0.08

0.67

u/ml

1.03

155

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.90

0.08

1.1

1.0

—

(40763791) Oxygen content in Venous blood by calculation

1.10

0.08

5.9

7.5

12.48

12.19

ml/dl

0.13

(3026726) Creatinine [Moles/volume] in Specimen

252

1.05

0.08

3.2

2.3

788.13

291.86

umol/l

0.77

243

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

230

1298

1.02

0.07

1.8

1.9

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

200

0.95

0.07

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

152

0.94

0.06

1.0

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

146

0.94

0.06

1.7

2.3

16.71

18.48

mmol/l

0.26

120

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

291

0.97

0.05

1.0

1.1

0.35

2.17

u/ml

1.37

219

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.11

0.05

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

308

0.97

0.05

1.0

0.46

0.11

u/ml

0.65

184

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

170

1.05

0.05

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

267

0.97

0.05

1.0

1.1

1.57

0.29

u/ml

0.69

147

(40758358) Immune stain study

131

1.05

0.04

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

309

1789

0.99

0.04

1.2

1.4

5.90

5.63

mmol/l

3.42

290

1690

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

378

2159

1.00

0.02

1.3

1.55

1.54

g/l

0.22

378

2159

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

190

1.03

0.02

1.0

0.31

1.57

u/ml

0.98

142

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

398

1.01

0.00

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

210

0.98

0.00

1.4

354.39

325.77

umol/24h

0.22

210

(40762887) Creatinine [Moles/volume] in Blood

0.97

0.00

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

100

1.03

0.00

1.1

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

130

1.02

0.00

1.0

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.02

0.00

1.1

1.0

0.18

0.05

u/ml

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.01

0.00

1.2

1.5

1.76

2.11

mmol/24h

0.44

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

187

0.98

0.00

1.0

1.1

60.58

24.22

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

187

0.98

0.00

1.0

1.1

20.40

24.82

u/ml

—

(40759632) Porphyrins [Mass/mass] in Stool

0.84

0.00

1.0

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.93

-0.00

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.90

-0.00

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.93

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_N05C and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_N05C	1.11 [1.04, 1.18]	0.001
Birth year	0.996 [0.99, 1.0]	0.3

During the follow-up period (1.1.1998 — 31.12.2019), 70922 out of 292693 females with RX_N05C died.

Males

Parameter	HR [95% CI]	p-value
RX_N05C	1.566 [1.46, 1.68]	< 0.001
Birth year	0.987 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 67683 out of 212291 males with RX_N05C died.

Mortality risk

Mortality risk for people of age

years, who have RX_N05C.

N-year risk	Females	Males
1	0.083%	0.214%
5	0.599%	1.512%
10	1.465%	4.079%
15	2.854%	7.63%
20	5.057%	12.536%

Relationships between endpoints

↥

Index endpoint: RX_N05C – Use of hypnotics and sedatives

GWS hits: 42

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Use of hypnotics and sedatives

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints